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CHAPTER 1: INTRODUCTION
Background and Clinical Significance
Chronic kidney disease (CKD) is identified as a public health priority because the
mortality rate due to CKD has risen by 82% over the past two decades (Lozano et al.,
2012; Mroue, Xu, Zhu, Morris, & Ramamoorthy, 2016; Radhakrishnan et al., 2014).
Cardiovascular (CV) morbidity and mortality are increased across all ages in patients with
CKD (Flynn, 2012), including those on dialysis and post renal transplantation.
Himmelfarb, Stenvinkel, Ikizler, and Hakim (2002) stated that “cardiac mortality for
dialysis patients aged 45 years or younger is more than 100-fold greater than in the
general population” p. 1524. Moreover, CV mortality in pediatric-onset renal failure is
1,000 times higher in comparison to the general population (Flynn, 2012) and accounts
for 25% of deaths due to cardiovascular disease (CVD) in children with end-stage renal
disease (ESRD) (Silverstein, Mitchell, LeBlanc, & Boudreaux, 2007). In children post
renal transplantation, CV mortality is 100 times higher than their age-matched population,
resulting in 40% of deaths due to cardiovascular disease (Kaidar et al., 2014) . Increased
CV morbidity and mortality in patients on dialysis and post renal transplant underscore
the importance of prevention through nutritional and life-style management strategies, as
well as treatment options aimed at decreasing the risk of CVD in the pediatric CKD
population.
According to the National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), nutritional intervention is a treatment strategy to delay progression of CKD and
reduce the risk of CVD (NIDDK, 2017). Delaying the progression of CKD will also reduce
the risk of CVD and other co-morbidities in the pediatric CKD population. Determining
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nutritional strategies for children with CKD may hold the key to delaying “disease
progression” in the pediatric CKD population.

This clinic-based, comparative cross-

sectional study was designed to evaluate the cardioprotective effects of dietary intake of
antioxidants and w-3 fatty acids in children pre-dialysis, during treatment with dialysis
(hemodialysis [HD] and peritoneal dialysis [PD]), and post renal transplantation.
Stages of Chronic Kidney Disease
Creatinine is a biomarker of kidney function. Glomerular filtration rate (GFR) is a
measure of renal function in both children and adults. A quick way to estimated GFR is
0.413 x (height in cm/serum creatinine) (Schwartz et al., 2009). CKD occurs in five stages.
Stages 1 to 4 indicate kidney damage, with a normal or high GFR in Stage 1, to a severely
low GFR in Stage 4. The GFR for the stages of CKD are as follows: Stage 1: GFR ≥ 90
mL/min per 1.73 m2; Stage 2: GFR 60-89 mL/min per 1.73 m2; Stage 3: GFR 30-59
mL/min per 1.73 m2; Stage 4: GFR 15-29 mL/min per 1.73 m2; and finally, Stage 5
indicates kidney failure with a glomerular filtration rate below 15 mL/min per 1.73 m2 and
requires dialysis or renal transplantation (" Kidney Disease Outcomes Quality Initiative
(KDOQI) Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update,"
2009). Since there is not a surrogate biomarker of kidney function in dialysis patients,
Kt/V is used to measure the adequacy of dialysis (Elshamaa et al., 2009). K measures
dialyzer clearance in milliliters per minute (mL/min), t stands for time, with Kt as a measure
of clearance multiplied by time for completely clearing urea during one treatment; and
finally, V is the volume of body water (NIDDK, 2009). To determine adequacy of HD,
estimates of Kt/V for < 1.0, < 1.2 and < 1.4 were used as a comparison (Goldstein, Brem,
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Warady, Fivush, & Frankenfield, 2006). Kt/V for adequacy of HD is at least 1.2 (NIDDK,
2009); whereas, adequacy of PD is at least 1.7 (KDOQI, 2006).
Co-morbidities of Chronic Kidney Disease
With an earlier age of onset of CKD, there is a greater risk of co-morbidities
associated with the disease. Co-morbidities of CKD include malnutrition, growth
retardation, joint pain, dental problems, hypertension, and CVD.
The pathogenesis of CVD in children with CKD is multifactorial. The pathogenesis
includes a) commonly known risk factors, such as elevated blood pressure, lipid
abnormalities, overweight/obesity, and deceased physical activity (Civilibal et al., 2007;
Lilien, Schroder, & Koomans, 2005); b) renal failure (uremia) related factors, such as
anemia, high parathyroid hormone, elevated phosphorus and calcium product, and
volume overload (Civilibal et al., 2007; Lilien, Schroder, et al., 2005); and c) novel risk
factors, such as systemic inflammation and oxidative stress (Elshamaa et al., 2009; Lilien,
Schroder, et al., 2005).
Poor blood pressure control remains an underlying risk factor for CVD in nearly
70% of children on HD, PD, and post renal transplantation (Flynn, 2012). Hypertension
remains a major concern and “clinically important risk factor” for CVD in children post
renal transplantation (Kaidar et al., 2014). Increased sodium (Na) intake is a risk factor in
the development of hypertension and preferences for consuming Na are developed
during childhood (Appel et al., 2015; IOM, 2013). In the United States, the average Na
intake is 3,400 mg/day (IOM, 2013) and 3,100 mg/day (Appel et al., 2015), in adults and
children respectively. The recommended guidelines for Na intake in adults is 2,300
mg/day (IOM, 2013). According to the Institute of Medicine (IOM), the upper limit (UL) for

4

the dietary reference intakes (DRI) of Na in children is as follows: 1) 1-3 years of age:
1,500 mg/day, 2) 4-8 years of age: 1,900 mg/day, 3) 9-13 years of age: 2,200 mg/day,
and 14-18 years of age: 2,300 mg/day (Appel et al., 2015; IOM, 2005b). Children and
adults in the United States consume excess Na in the diet which is a contributing factor
to the development of CVD in patients with CKD (Appel et al., 2015; IOM, 2013).
Moreover, increased intake of dietary Na increases albuminuria and lowers serum
albumin levels (Hui et al., 2017). Albumin levels reflect protein status and affect growth.
According to Hui et al., 2017, children with CKD experience growth failure due to reduced
energy intake and protein wasting. The IOM’s dietary reference intakes (DRI) of protein
based on age are as follows: 1) 1-3 years of age: 1.05 g/kg/day or 13 g/day, 2) 4-8 years
of age: 0.95 g/kg/day or 19 g/day, and 3) 9-13 years of age: 0.95 g/kg/day or 34 g/day
(IOM, 2005a). The estimated average protein requirement for adolescents 14 -18 years
of age is 0.73 g/kg/day and 0.71 g/kg/day, in boys and girls respectively (IOM, 2005a).
According to the KDOQI, children with CKD require a daily protein intake at 100-140%
(stage 3) and 100% (stages 4-5) of the DRI per ideal body weight ("KDOQI Clinical
Practice Guideline for Nutrition in Children with CKD: 2008 Update," 2009). A high body
mass index (BMI), indicating obesity, and a low BMI, reflecting growth failure, place
children in ESRD at increased risk for mortality (Hui et al., 2017)
Accumulation of uremic toxins due to deficient renal clearance contributes to
endothelial dysfunction leading to CVD in adults and children alike (Himmelfarb et al.,
2002; Moradi, Sica, & Kalantar-Zadeh, 2013). Urea is a product of protein catabolism
(Vartia, 2013) and uremic toxins contribute to “the progression of cardiovascular disease
in patients with CKD” (Moradi et al., 2013, p. 136). In CKD, uremia also decreases red
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blood cell survival contributing to anemia (Elshamaa et al., 2009) and anemia is a
contributing factor for increased lipid peroxidation and CVD (Elshamaa et al., 2009).
In addition to the accumulation of uremic toxins, components of HD, such as the
access device and filter membrane, promote inflammation and oxidative stress
(Elshamaa et al., 2009; Himmelfarb et al., 2002; Lilien, Koomans, & Schroder, 2005).
Components of PD, such as the dialysate, damage the endothelial structure and impairs
endothelial function. (Covic, Goldsmith, Florea, Gusbeth-Tatomir, & Covic, 2004; Lilien,
Schroder, et al., 2005). Moreover, other mediators, such as hypertension, anemia, and
elevated high sensitivity C-reactive protein (hs-CRP) are cardiovascular risk factors in
children with ESRD (Civilibal et al., 2007).
Oxidative Stress
Oxidative stress is a known risk factor for CV morbidity in patients with uremia.
Free radical damage begins early in CKD progression, well before treatment with dialysis,
and results in the formation of inflammation and atherosclerosis leading to CVD
(Dounousi et al., 2006; Elshamaa et al., 2009; Schmidl & Labuza, 2000). Oxidative stress
results from an imbalance between antioxidant activity and pro-oxidants leading to free
radical damage (Himmelfarb et al., 2002; Schmidl & Labuza, 2000). Free radicals, such
as hydroxyl radical (OH∙), superoxide radical (O2∙-), nitric oxide radical (NO∙), and lipid
peroxyl radical (LOO∙) are unstable, damaged molecules that react with other molecules
in the body leading to cellular injury and disease (Schmidl & Labuza, 2000).
Polyunsaturated fatty acids, due to their numerous double-bonds, are easily oxidized in
vivo by free radicals and other reactive oxygen species (Daschner et al., 1996)
Peroxidation of arachidonic acid (C20:4, w-6) causes free-radical injury through
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prostaglandin-like compounds called isoprostanes (ISOP) (Osorio, Ferreyra, Perez,
Moreno, & Osuna, 2009). 8-Isoprostanes (8-ISOP) are the most reliable biomarkers of
oxidative stress in vivo (Osorio et al., 2009) and are reliable for use in patients with uremia
(Dounousi et al., 2006). Thiobarbituric Acid Reactive Substances (TBARS) reliably
measures malondialdehyde (MDA), a water-soluble lipid peroxidation product of
polyunsaturated fatty acids resulting from cellular injury and is another indicator of
oxidative stress in uremia (Daschner et al., 1996).
A study of pediatric patients on HD (n = 10) and PD (n = 11) showed that elevated
plasma MDA levels were due to oxidative damage from uremia rather than from the
dialysis treatment itself (Daschner et al., 1996). Kotur-Stevuljevic et al. (2013) found that
MDA, a marker of oxidative stress, was “markedly increased” and superoxide dismutase
(SOD), a marker of oxidative defense, was “compromised” in 52 pediatric patients (n =
10 with CKD, n = 22 post renal transplant, and n = 20 on HD; compared to a control group
of 36 healthy children). The authors also concluded that atherosclerosis begins early in
children with CKD in response to oxidative stress and dyslipidemia (Kotur-Stevuljevic et
al., 2013).
ABTS (2,2’-Azino-di-[3-ethylbenzthiazoline sulphonate]) is used for measuring
total antioxidant capacity in vivo by metmyoglobin in plasma and other body fluids
(Cayman, 2016). The ABTS assay measures the ability of antioxidant systems, including
detoxification enzymes, macromolecules (such as, albumin and ferritin) and small
molecules (such as, b-carotene, ascorbic acid, a-tocopherol, and uric acid) to reduce
oxidative stress and cellular damage (Cayman, 2016).
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Dietary Antioxidants and Omega-3 Fatty Acids
Vitamin C, a well-known antioxidant, improves endothelial function (ED) and
lessens the risk of CVD, especially in patients who are at increased risk for CVD (Ashor,
Lara, Mathers, & Siervo, 2014) and is a cofactor with iron to boost red blood cell
production and improve states of anemia. According to the Food and Nutrition Board,
Institute of Medicine, National Academies, (www.nap.edu), the recommended dietary
intake of vitamin C for children by age is as follows: 1–3 years: 15 mg, 4–8 years: 25
mg, 9–13 years: 45 mg, boys 14–18 years: 75 mg, and girls 14–18 years: 65 mg.
Intima media thickness (IMT) and brachial artery flow-mediated dilation (FMD) are
measures of ED in CVD. In an experimental study that administered 250 mg/day of
vitamin C for 1 month duration to 18 children with CKD (9 on HD, 4 on PD, 3 on
pharmacological treatment, and 2 post renal transplant) and to a control group of 19
children without CKD, found that vitamin C significantly reduced the IMT in the
experimental and control groups (p < 0.05) and increased the brachial artery FMD in both
groups reaching statistical significance in the control group (Sabri, Tavana, Ahmadi, &
Gheissari, 2015). Administration of 250 mg/day of intravenous (IV) vitamin C after HD
sessions three times a week for 12 weeks was also found to significantly reduce uric acid
and improve the lipid profile in children on HD (n=30) compared to the placebo group
receiving IV saline (n=30) (El Mashad, ElSayed, & Nosair, 2016).
Vitamins C helps to control blood pressure. A meta-analysis of randomized
controlled trials for the effects of vitamin C on blood pressure reported that vitamin C
lowered both SBP and DBP in short-term trials (Juraschek, Guallar, Appel, & Miller,
2012). In addition to improving endothelial function, vitamin C helps to form the basement
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membrane of blood vessels by Type IV collagen formation and functions as an antioxidant
in free radical scavenging (May & Harrison, 2013).
Carotenoids, such as b-carotene, lycopene, and lutein, as well as other
carotenoids, act as antioxidants and pro-oxidants in humans and animals (Fiedor &
Burda, 2014). The fine balance between antioxidant and pro-oxidant activity is important
to human health because loss of antioxidant activity “results in oxidative stress”
contributing to chronic health conditions, such as CVD, cancer, neurological disorders,
immune diseases, and visual impairment (Fiedor & Burda, 2014). Beta-carotene is a
carotenoid and an antecedent to vitamin A (retinol). Retinol (ROH) and the transport
protein for vitamin A, retinol-binding protein (RBP), accumulate when the kidneys are
impaired and the glomerular filtration rate is reduced ("KDOQI Clinical Practice Guideline
for Nutrition in Children with CKD: 2008 Update," 2009). Vitamin A is not cleared by
dialysis. Fassinger, Imam, and Klurfeld (2010), studied two groups of children receiving
dialysis (children < 12 years: HD, n = 8; PD, n = 19) and (children > 12 years: HD, n = 19;
PD n = 29) and found that children in ESRD had elevated serum levels of ROH, RBP,
and transthyretin (TTR). In children with CKD, supplementation with vitamin A is only
indicated for individuals with very low dietary intake ("KDOQI Clinical Practice Guideline
for Nutrition in Children with CKD: 2008 Update," 2009). The upper limit for
supplementation of preformed vitamin A by age for children is as follows: 1–3 years:
2,000 IU, 4–8 years: 3,000 IU, 9–13 years: 5,667 IU, and 14–18 years: 9,333 IU
(www.nap.edu).
Beta-carotene works synergistically as an antioxidant with vitamin E, mainly atocopherol, to trap free radicals (Fiedor & Burda, 2014). Vitamin E demonstrates the
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ability to protect the heart and kidneys through anti-inflammatory and lipid-lowering
activity (Daud et al., 2013; Fiedor & Burda, 2014). Studies on vitamin E in children with
CKD were not found in the literature. A randomized, double-blind, placebo-controlled
study by Daud et al. (2013) demonstrated that oral administration of vitamin E
tochotrienol-rich fraction (TRF) in a dosage of 180 mg tocotrienols and 40 tocopherols
twice daily improved lipid profiles at 12 and 16 weeks in elderly patients (age > 65 years)
receiving HD.
Trace minerals, such as copper, selenium, and zinc are monitored in children with
CKD ("KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008
Update," 2009). Trace minerals are monitored to assess for signs of deficiency or excess.
Low serum copper and low serum zinc levels may result from poor nutrition or removal
by dialysis; whereas, selenium is not removed by dialysis ("KDOQI Clinical Practice
Guideline for Nutrition in Children with CKD: 2008 Update," 2009). Moreover, the amount
of selenium in food depends on the soil and low serum selenium levels are noted in
children with CKD ("KDOQI Clinical Practice Guideline for Nutrition in Children with CKD:
2008 Update," 2009). Selenium works with glutathione peroxidase and other enzymes to
function as a free radical scavenger and antioxidant (Loo, 2009). The RDI for children for
selenium, zinc, and copper are 15–55 µg/day, 2-11mg/day, and 200-900 µg/day
respectively (Loo, 2009).
Omega-3 fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid
[DHA]) are known to have anti-inflammatory and cardioprotective properties and have
been studied in children and adults on dialysis (Daud et al., 2012; Goren, Stankiewicz,
Goldstein, & Drukker, 1991; Zhu et al., 2014).

Daud et al. (2012) conducted a
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randomized, placebo-control pilot study of 63 patients, age 18 years and older (on HD for
> 3 months) to determine the effects of protein and w-3 supplementation on lipid profiles,
nutritional parameters and inflammatory indices. The patients in the study received an w3 supplementation (total DHA 600 mg and total EPA 1800 mg; n= 31) or a placebo of
olive oil along with protein supplementation three times a week during dialysis treatment
(Daud et al., 2012). The findings of this study showed that w-3 supplementation treatment
had a favorable effect on the lipid profile and C-reactive protein levels (Daud et al., 2012).
Plasma fatty acid composition was studied in children (6 – 18 years of age) to determine
the effects of estimated intake of nutrients on the risk for CVD in post renal transplant
patients (Aldamiz-Echevarria et al., 2004). Nutrient intake pattern of these children
included: 1) high intake from oleic acid (C18:1), a monounsaturated fatty acid (MUFA)
mainly derived from olive oil (mean 0.7 g/kg/day; 20% of energy intake from MUFAs/day),
2) lower intake of saturated fatty acids (13% of energy intake/day) compared to
unsaturated fatty acids (26% of energy intake/day), and 3) 39% energy intake/day from
total fat which was above the recommendation (30%) for children with renal disease
(Aldamiz-Echevarria et al., 2004). Results showed that intake of nutrients from MUFAs
and polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid lowered total
cholesterol, LDL-C, and apolipoprotein A (Aldamiz-Echevarria et al., 2004). Consistent
with previous literature, and as reported in this study, the authors suggest that cis fatty
acid, oleic acid, may increase plasma HDL-C and recommend that total fat intake (10%
total calorie intake/day from each saturated fat, MUFA and PUFA), as well as intake of
linoleic acid be limited to 3-6 g/day to prevent desaturation competition with w-3 fatty acids
in children post renal transplantation (Aldamiz-Echevarria et al., 2004).
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The effects of dietary intake of antioxidants and w-3 fatty acids on biomarkers to
measure oxidative stress (8-ISOP, TBARS, and ABTS) in children with CKD at various
stages of treatment are unknown even though adequate intake of antioxidants and w-3
fatty acids may benefit children with CKD. Similarly, the intakes of antioxidants and w-3
fatty acids of these children are not documented. To the best of our knowledge, this was
the first clinical study that is uniquely involved in researching the dietary effects of
antioxidants and w-3 fatty acids on “disease progressive oxidative stress” in children at
various stages of CKD.
Overall Objective
The purpose of this study was to understand the relationship between dietary
intake of antioxidants and w-3 fatty acids on free radical injury and free radical scavenging
in children with CKD so that complications of kidney failure, especially cardiovascular
disease, may be avoided or delayed.
Specific Aims
Aim #1: To test the hypothesis that high dietary intake of antioxidants and w-3
fatty acids would lower free radical damage, as measured by lipid peroxidation products
(8-ISOP & TBARS) in children with chronic kidney disease pre-dialysis, during treatment
with dialysis (HD and PD), and post renal transplantation.
Aim #2: To test the hypothesis that high dietary intake of antioxidants and w-3 fatty
acids would produce better free radical scavenging ability, as measured by ABTS levels
in children with chronic kidney disease pre-dialysis, during treatment with dialysis (HD
and PD), and post renal transplantation.
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Aim #3: To test the hypothesis that children with CKD and high dietary intake of
antioxidants and w-3 fatty acids would have a better metabolic profile and bone health as
compared to those with lower intake of these nutrients.
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CHAPTER 2: METHODS
Design and Setting
This clinic-based, comparative cross-sectional study investigated children of both
genders, 3 to 21 years of age, receiving treatment in the nephrology clinic pre-dialysis
and post renal transplantation, as well as children on HD and PD treated in the dialysis
units at Children’s Hospital of Michigan (CHM), Specialty Center (Detroit, MI).
Treatment Groups
1. Pre-dialysis: CKD stages 2 to 4
2. Hemodialysis: CKD stage 5
3. Peritoneal Dialysis: CKD stage 5
4. Post Renal Transplantation
Inclusion Criteria
Inclusion criteria were: (1) children diagnosed with CKD receiving treatment predialysis, during treatment with dialysis (HD and PD), and post renal transplantation at
CHMs - Specialty Center; (2) age 3 to 25 years; (3) on dialysis for at least 3 months prior
to entering the study, and (4) renal transplant patients on follow-up in the nephrology clinic
and at least 3 months after surgery for recent transplant. The inclusion criterion for
children on dialysis for at least 3 months is supported by previous research (Elshamaa et
al., 2009; Tsai et al., 2010; Zimmerman et al., 2014).
Exclusion Criteria
Exclusion criteria included: (1) diseases of the liver and spleen, (2) human
immunodeficiency virus (HIV) infection, (3) cancer, (4) hematological disorders, and (5)
inflammatory disorders. Infectious diseases, inflammatory disorders, and cancer may
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alter the results of biomarkers of oxidative stress and were therefore listed in the exclusion
criteria for this study.
Participants
Participants in this study were children. Children’s Hospital of Michigan is one of
the first in the state to provide outpatient dialysis services to children. Children were
recruited from the HD unit, PD unit, and nephrology clinic at the Children's Hospital of
Michigan, Specialty Center. The HD unit has provided chronic dialysis services on
average to 15 children at any given time point per year, with clinic visits scheduled three
times a week, on Monday, Wednesday, and Friday. The PD unit also services, on
average, 15 children at any given time point throughout the year; although, as determined
by the exclusion criteria, children under 3 years of age were not eligible to participate in
this study. Children on PD were seen during their monthly follow-up appointment in the
clinic. The nephrology clinic services on average 60 to 70 pre-dialysis children and 20 to
40 kidney transplant children per year. In this study, we enrolled a total of 47 children: 15
children in the pre-dialysis treatment group, 11 children in the HD treatment group, 6
children in the PD treatment group, and 15 children in the post-transplant treatment group.
Institutional Review Board Approval, Informed Consent and Assent
Institutional Review Board approval was obtained from the Detroit Medical
Center/Children’s Hospital of Michigan and from Wayne State University. A pediatric
nephrologist informed the children and their parents/caregivers about this study during
their routine office visits, and if the children and parents/caregivers were interested,
consents from the parents and assent, for children 13 years and older, were obtained by
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the RN Principal Investigator or the Pediatric Nephrologist. Each participant was identified
by a code number for data collection and analysis.
Data Collection
Demographic data (age, gender, race/ethnicity, financial status, household
composition, modes of transportation) on each participant was collected at the start of the
study. Demographic data was collected by the RN Principal Investigator by means of
interview and data obtained from the child’s electronic medical records (EMR).
Anthropometric measures - Both weight and height measures were carefully
obtained by the clinic RNs since undernutrition and edema are complicating factors
present in children with CKD ("KDOQI Clinical Practice Guideline for Nutrition in Children
with CKD: 2008 Update," 2009).

Age and gender specific body mass index (BMI)

percentile and z-scores were then calculated or obtained from the child’s EMR at the start
of the study.
24-hour diet recall and prospective 3-day dietary records – The KDOQI Clinical
Practice Guideline for Nutrition in Children with CKD: 2008 Update recommends
assessing nutritional intake by means of a prospective 3-day dietary records, as
instructed by a skilled registered dietitian. The nutritional management of children with
CKD was coordinated by the renal dietitian in collaboration with other members of the
multidisciplinary pediatric nephrology team ("KDOQI Clinical Practice Guideline for
Nutrition in Children with CKD: 2008 Update," 2009). As part of this team, the RN
Principal Investigator was responsible for obtaining a 24-hour diet recall (identified by a
code number) during a routine clinic visit and children and their parents/caregivers were
asked to return, within one week, the prospective 3-day dietary records (identified by a
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code number) in a self-addressed, stamped envelope addressed to the investigators in
the Department of Nutrition & Food Science at Wayne State University. A five-dollar
($5.00) gift card was offered as an incentive for completing and returning the 3-day dietary
records. During the dietary recall data collection, food models and measuring devices
were provided to the child or parents/caregivers to assist them to identify the amount of
each food consumed. A multi-passage method was used to collect the dietary recall data
(Johnson, Driscoll, & Goran, 1996). In this procedure, during the “first pass”, the child or
parents/caregivers were asked to write down everything the participant ate over the
previous 24 hours (Johnson et al., 1996). The “second pass” clarified the types of food
eaten at meals and snacks. Finally, the “third pass”, defined portion sizes of each food
entered on the dietary records (Johnson et al., 1996). At the end of the dietary recall, 3day dietary record forms were given to the child or parents/caregivers. In this form,
spaces were provided to record food items consumed at breakfast, mid-morning snack,
lunch, mid-afternoon snack, dinner and evening snack. Spaces were provided to record
serving size, preparation methods, brand names or restaurant names. An instruction
sheet was also provided to the child or parents/caregivers to remind them about the
information that was needed to complete the food diary. The 3-day dietary records
included two weekdays and one weekend day. Dietary intake as recorded in the dietary
records/recall records was analyzed.
The database and software Food Processor® Nutrition Analysis by EHSA (Version
11.3.285, Salem, OR, USA) were used to analyze nutrient intakes. A “lightly active”
physical activity level was used as a basis for analyzing nutrient intakes on all diet records.
Only 13% of adolescent with CKD meet the recommended guidelines set by the American
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Academy of Pediatrics for physical activity in children (Clark, Denburg, & Furth, 2016; Hui
et al., 2017).
Routine laboratory testing – Blood samples were obtained during routine blood
draws performed by a skilled dialysis nurse or phlebotomist according to hospital protocol.
Standard laboratory methods for processing the specimens and measuring routine
laboratory tests were analyzed by Detroit Medical Center laboratories. Routine laboratory
testing (clinical measures) included serum levels of hemoglobin (Hgb), albumin, ferritin
(Fe), sodium (Na), potassium (K), blood urea nitrogen (BUN), creatinine, calcium (Ca),
phosphorus (P), magnesium (Mg), parathyroid hormone (PTH), total cholesterol (TC),
high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C),
triglycerides (TG), and TC/HDL-C.
Oxidative stress (8-ISOP, TBARS and ABTS) measurements – From routine
laboratory blood draws, an additional 3 mL of blood were collected from each child in a
heparinized vacutainer. The samples were labeled (identified by a code number) and
transported in a cooler, on ice, to a laboratory in Department of Nutrition & Food Science
at Wayne State University.

All blood samples were centrifuged at 1,000 x g for 10

minutes at 4°C. Plasma was then separated and stored in small aliquots in a -80 °C
freezer until assays were performed later.
ABTS Antioxidant Assay:

Antioxidant Assay Kits from Cayman Chemical

Company (Ann Arbor, Michigan, United States) were used to determine free radical
scavenging ability. ABTS antioxidant assay has an intra-assay coefficient of variation of
3.4%, with an assay range of 0.044 to 0.330 mM Trolox standards (Cayman, 2016).
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Assay procedures were implemented and data were analyzed according to Trolox
standard curves per the instruction manual provided by Cayman Chemical Company.
8-ISOP Assay: 8-Isoprostane EIA Kits from Cayman Chemical Company (Ann
Arbor, Michigan, United States) were used to determine lipid peroxidation (Yu & Navab,
2007). The measuring range for 8-Isoprostane ELISA is based on a dose concentration
of 2 to 500 pg/mL. Samples were purified and stored at -80°C in the presence of 0.005%
BHT (10 µl of 5 mg/ml solution in ethanol per 1 ml sample) according to pre-assay
preparation procedures. Assay protocol and analysis were implemented per the
instruction manual provided by Cayman Chemical Company. All samples were measured
in one single assay.
TBARS Assay: TBARS Assay Kits from Cayman Chemical Company were used
to determine lipid peroxidation (McDonald et al., 2004). This assay has an intra-assay
variability of 5.5%, with an assay range of 0 to 50 µM MDA equivalents (Noguchi &
Tanaka, 1995). All TBARS assay results in each of the treatment groups were within the
range of 0 to 50 µM MDA equivalents. Pre-assay preparation, assay protocol, and
analysis were implemented according to the instruction manual provided by Cayman
Chemical Company.
Blood pressure measures - For accurate measures of systolic and diastolic blood
pressure, an appropriate size blood pressure cuff was used on each child.

Blood

pressures were obtained from the arm using an electronic blood pressure machine while
the child was seated. A skilled dialysis nurse or registered nurse in the clinic obtained
and recorded the blood pressure readings in the EMR according to hospital protocol.
Routine blood pressure readings, as recorded in the EMR, were used in this study.
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Bone Health - To establish a bone health profile, we calculated an antioxidant
index by first standardizing intakes of vitamin A, b-carotene, vitamins C, E and selenium.
The z scores were added together to produce an index for antioxidant intake. In addition,
z score of w-3 fatty acids was added to the antioxidant index to produce another index
representing antioxidants + w-3 fatty acids intake. Then, these indices were divided
equally into three parts to generate categorical variables for mean comparisons, 1 being
the lowest one third of the index and 3 being the highest of the index.
Renal Metabolic Profile - To calculate renal metabolic profile, normal ranges of the
following minerals were used: Na: 135-137 mEq/L; K: 3.5-5.3 mEq/L; Ca: 8.8-10.1 mg/dL;
Mg: 1.5-2.6 mg/dL; P: 4.1-5.5 mg/dL. Metabolic wastes were considered normal when
BUN levels were below 20 mg/dL and creatinine levels were below 0.7 mg/dL. For
minerals, any values outside of the normal ranges were considered as unhealthy while
any values above the metabolic wastes were treated as unhealthy. Since only a few
children had serum mineral levels outside of the normal ranges, we created a composite
score using z scores for BUN and creatinine only as an indicator of renal function (Renal
profile 2). Renal profile 2 was an indicator of poor renal function in children in the nondialysis group (pre-dialysis and post renal transplant). GFR was used as an indicator of
adequate renal function also in children not on dialysis; whereas, Kt/V was used to
measure adequacy of dialysis in children on HD and PD.
Data Analysis
Mean and standard deviation (SD) or standard error of mean (SEM) were
calculated for each group and for each parameter measured. Statistical Package for
Social Sciences (SPSS) software (Version 22, IBM, Armonk, NY, USA) was used for data
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analysis. Statistical methods included correlation analysis, analysis of variance (ANOVA),
and post-hoc t-tests. Dependent variables included 8-ISOP, TBARS, ABTS and other
routine laboratory tests including serum levels of hemoglobin, albumin, blood urea
nitrogen, ferritin, calcium, phosphorus, parathyroid hormone, and lipid profile, SBP, DBP,
and BMI percentile. Correlation analysis determined the relationships between dietary
intake of antioxidants and w-3 fatty acids as well as other nutrients with 8-ISOP, TBARS,
ABTS, routine laboratory results, SBP, DBP, and BMI percentile. ANOVA tests were
conducted to determine differences among the four comparative groups or different
stages of CKD. If a significant difference was identified among the groups, post-hoc ttests were performed to identify the groups that contributed to the overall difference. The
significance level was set at p<0.05.
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CHAPTER 3: RESULTS
Demographic Data
There were 34 male (72.3%) and 13 female (27.7%) children recruited into this study.
The age range of children in this study was from 3 to 21 years of age. The mean age
was 12.2±5.2 years (Mean ± SD). The age range was divided into four categories for
statistical analyses: younger than 6 years (n=10), 7 – 12 years (n=14), 12 – 18 years (n=14)
and older than 18 years (n=9). Age by treatment distribution is shown in Table 1. Differences
in age by treatment were not evident. Gender by treatment was as follows: 1) pre-dialysis:
73% males, 27% females; 2) HD: 64% males; 36% females; 3) PD: 50% males, 50% females;
and 4) post-renal transplant: 87% males, 13% females. Racial and treatment distribution is
shown in Table 2. Lower percentage of African American children were in the post-transplant
group than that of the White or Hispanic groups, but the difference was not statistically
significant (p=0.06).

Anthropometric Measures
No difference was noted in the BMI percentiles and z scores for the pre-dialysis, HD, PD,
and post-transplant treatment groups (Table 3).

There was no difference in the

distribution of BMI categories in treatment groups (data not shown).
Clinical Measures
The systolic blood pressure (SBP) in each age group was within the normal
recommended blood pressure range for age. Only the 6 – 10-year age group had
significantly lower diastolic blood pressure (DBP) than recommended. Table 4 shows the
comparison of blood pressure and recommended blood pressure ranges by age. Figure
1 shows that among the four groups of children, SBP readings were similar; whereas,
DBP readings were higher among children on dialysis.
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Table 5 shows hemoglobin (Hgb) levels according to age categories. All age
groups had similar Hgb levels. No difference was noted in Hgb levels in children younger
than 6 years of age and the normal level. Children ages 6-12 years, 12-18 years, and
males older than 18 years of age had significantly lower Hgb levels than normal (p<.001).
Females older than 18 years of age also had lower Hgb levels than normal (p<.01).
Table 6 depicted the routine clinic measures for the four treatment groups.
Hemoglobin levels of the four groups were significantly different from each other.
Children on PD had significantly lower Hgb levels than that of the non-dialysis group but
similar to that of children on HD.
Among the four treatment groups, serum albumin levels were significantly lower in
the PD group (p<.001) than the other three groups. Blood urea nitrogen (BUN) levels
were higher in children on HD and PD (p<.0001) than the levels in pre-dialysis and posttransplant groups. BUN levels were lowest in the post-transplant group. A similar pattern
was observed for serum creatinine levels but no difference in creatinine levels between
the two non-dialysis groups was observed (p<.0001).
In the PD group, serum Fe levels were significantly higher than the other two
groups (p=.001). Serum ferritin levels were not ordered in the post-transplant group.
Serum Na, K and Ca levels were not statistically different among the four treatment
groups. Serum P were higher in the dialysis groups than that of pre-dialysis and posttransplant groups (p=.001). Serum Mg levels were also higher in the dialysis groups than
the levels observed in the pre-dialysis and post-transplant groups. Magnesium in the
post-transplant group was significantly lower than the pre-dialysis group (p<.0001).
Parathyroid hormone (PTH) levels were higher in children on PD as compared to children
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pre-dialysis and on treatment of HD (p=.005). Only one child in the post-transplant group
had a PTH level measured.
Although TC, HDL-C and LDL-C levels were not statistically different among the
four treatment groups, HD and post-transplant groups had lower TC/HDL-C levels than
the pre-dialysis group (p=0.019). TG levels in the HD and post-transplant groups were
similar and both were lower than that of the pre-dialysis and PD groups.
The post-transplant group had lower BUN and creatinine levels per renal profile 2
scores than in the pre-dialysis group (p<.001). The GFR was higher in the post-transplant
group than in the pre-dialysis group (p<.0001). Among children on dialysis, the Kt/V was
higher in the PD group than in the HD group (p=.001).
Biomarkers for Free Radical Injury and Free Radical Scavenging
Table 7 shows the comparisons of biomarkers for free radical injury (8-ISOP &
TBARS) and free radical scavenging (ABTS) in the four treatment groups. Less free
radical scavenging, as measured by ABTS (p=.015), was noted in the PD and posttransplant groups while the pre-dialysis, HD and PD groups had similar ABTS levels. No
differences were noted among treatment groups for free radical injury, as measured by
8-ISOP and TBARS.
Relationships between Clinical Measures (Table 8)
All children: When all children were considered, SBP was significantly correlated
with DBP. DBP was correlated with creatinine. Hemoglobin was positively correlated
with albumin, but negatively with BUN, creatinine, Fe, P and PTH. Albumin was positively
correlated with BUN and negatively correlated with creatinine, Fe, PTH, TC, TG, LDL-C
and TC/HDL ratios. BUN showed positive relationships with creatinine, Mg, and P.
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Creatinine was positively correlated with Mg, P, and LDL-C levels. Serum Fe showed
positive relationship with Mg and PTH. Serum Na was positively correlated with serum
LDL-C and TC/HDL levels. Serum K had positive relationships with Mg and TG. Serum
Ca was positively correlated with Mg but negatively with TG. Serum Mg showed a positive
correlation with P. Serum P was positively correlated with PTH. Serum TBARS was
negatively correlated with serum Mg while ABTS levels were positively related to serum
BUN, K and Ca. PTH levels showed a positive relationship with TG and a non-significant
positive correlation with 8-ISOP.
Pre-dialysis: For the 15 pre-dialysis children, SBP was positively correlated with
creatinine and negatively with serum Mg. SBP also showed positive relationships with
DBP and serum Na but the correlations failed to reach statistical significance. DBP was
inversely related to BUN. Hemoglobin levels showed negative correlation with serum P.
Albumin was negatively correlated with serum Fe but positively with serum Ca. Serum
Na showed positive relationships with creatinine and K. PTH and 8-ISOP were positively
related but failed to reach statistical significance.

Renal profile 2 was negatively

correlated with serum Hgb but positively correlated with TBARS and 8-ISOP.
Dialysis: Seventeen children were either on HD or PD. SBP revealed inverse
correlations with BUN and serum Fe. Hemoglobin levels were negatively correlated with
serum Fe, PTH, and 8-ISOP. Albumin and serum Mg as well as ABTS were positively
correlated but albumin and PTH were negatively correlated. BUN was positively related
to TBARS. Serum Fe and Mg as well as 8-ISOP showed positive relationships. Serum
Na was positively correlated with Mg but negatively with P. PTH and TG, TC/HDL-C and
8-ISOP were positively correlated. Kt/V was negatively correlated with SBP and creatinine
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and showed a non-significant negative correlation with Hgb.

Kt/V had positive

correlations with TC and TG. KTt/V was positively related to PTH but failed to reach
statistical significance.
Post-transplant: For the 15 post-transplant children, SBP was positively correlated
with DBP, Hgb, albumin, creatinine, and Mg. The negative relationship between SBP and
serum Ca missed statistical significance. DBP was positively correlated with creatinine
and negatively with Ca. Albumin was positively related with Hgb and Mg levels but
negatively with serum Fe levels. Serum Fe and PTH showed a positive relationship.
Serum K was positively related to Mg and P, while serum P was positively correlated with
TBARS.
Non-dialysis: Thirty children were not treated with dialysis (pre-dialysis and posttransplant groups). For this group of children, SBP was positively correlated with DBP
and Hgb while DBP was negatively correlated with BUN. The relationships of Hgb was
positive with albumin but negative with BUN and P. Serum albumin was inversely
correlated with TC, LDL-C and TC/HDL-C. Serum BUN and K, P and ABTS showed
significant positive relationships. Serum creatinine was positively related to serum Na, K,
TC, TG, LDL-C and TC/HDL-C ratios. Serum Na was negatively correlated with Ca but
positively correlated with TG, LDL-C and TC/HDL-C ratios, whereas serum Na and TC
missed statistical significance. Serum Mg inversely correlated with HDL-C levels. ABTS
levels were positively related to BUN, P and K but negatively although non-significantly
with PTH. Renal Profile 2 was inversely correlated with DBP and Hgb, but positively
correlated with K, TG, and ABTS. The GFR negatively correlated with BUN, serum Na,
K, Mg, TG, TC/HDL-C and missed positive statistical significance with serum Ca.
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Relationships between Oxidative Stress and Scavenger Biomarkers and Blood
Lipid Profile (Table 9)
All children: In all 47 children, 8-ISOP positively correlated with TG and TC/HDLC and negatively correlated with HDL-C. TBARS positively correlated with TC and LDLC; whereas, the correlation with TG missed statistical significance.

No relationship

between ABTS and blood lipid levels were identified.
Dialysis: In 17 dialysis children, 8-ISOP positively correlated with TG and TC/HDLC and negatively correlated with HDL-C, although missed statistical significance. ABTS
negatively correlated with TG. ABTS showed negative relationships with TC and TC/HDLC, although failed to reach statistical significance. TBARS was not related to any of the
blood lipid parameters.
Non-dialysis: In 30 children not on dialysis, 8-ISOP positively correlated with TG
and TC/HDL-C and negatively correlated with HDL-C. TBARS positively correlated with
TC and LDL-C. No relationship between ABTS and blood lipid levels were observed.
Dietary Measures
Nutrient Intakes from 24-Hour Diet Recall
Table 10 shows nutrient intakes of the four groups based on 24-hour diet recall
records. Only the nutrients that contribute to the bone health and kidney disease are
presented. Compared to children in the pre-dialysis and post-transplant groups, children
in the two dialysis groups had significantly lower total daily caloric intake (kcal/day);
although, the energy intake of the PD and post-transplant groups were similar. Similar
patterns were observed for calories and grams from total fat and saturated fat (SAT). No
differences were observed among the four groups for total protein and carbohydrate

27

(CHO) intakes. No differences were observed in w-3, and w-6 fatty acids (FAs) intakes
among the four groups.
Protein intakes (g/kg), either based on 24-hour diet recall or 3-day dietary records,
were analyzed according to the age distribution used by the National Academy of Science
(NAS, www.nap.edu). The data showed significantly different intakes among the four age
groups. Younger children consumed more protein compared to older children but all age
groups consumed significantly higher amount of protein as compared to the
Recommended Daily Intake (RDI) for each age group as shown in Table 11.
Micronutrient intake for water soluble and fat soluble vitamins, as well as mineral
and water intake did not significantly differ among the four treatment groups, except for
calcium intake which was significantly lower in children on HD as compared to nondialysis groups while children in the PD group had calcium intake that was not different
from the other three groups (p=0.001).

Sodium intakes were significantly lower among

children on HD and PD than that of the other two groups (p=0.003). However, Na intakes
were not different among the four age groups and not different from the NAS Na
recommended intake either (Table 12).
Total antioxidant intake: Since we hypothesized that total antioxidant intake and
w-FAs intake would improve the metabolic profile in CKD children, we calculated total
antioxidant intake, with or without added w-FAs, for both 24-hour diet recall and 3-day
dietary records.

This was accomplished by standardizing intakes of vitamin A, β-

carotene, vitamin C, vitamin E and selenium. The resulting z scores for these nutrients
were summed together to produce composite scores for total antioxidants and total
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antioxidant plus w-3 FAs. The total antioxidant z scores and antioxidant plus w-FAs z
scores from 24-hour recall were not different among the four treatment groups.
Nutrient Intakes from 24-Hour Diet Recall as Percent Recommended
Table 13 shows the percent recommended nutrient intakes in all four groups based
on 24-hour diet recall records. Based on the percent recommended, daily energy intake
was lower in HD children although the difference failed to reach statistical significance (p
= 0.061). Whereas, total SAT intake and calories from SAT were lower among children
on HD and PD than that of pre-dialysis and post-transplant children (p=0.022 and
p=0.022, respectively). However, intakes of w-3 and w-6 fatty acids as percent of
recommendations were not different among the four groups, but all were less than 35%
of the recommendations for w-3 FA intake.
The micronutrient intake as percent of recommended for water soluble and fat
soluble vitamins, as well as mineral and water intake did not significantly differ among the
four treatment groups, except for Ca intake. The Ca intake as percent of recommended
was significantly lower in children on HD than in pre-dialysis and post-transplant children
but not different from the children on PD (p=0.003).

The Ca intake as percent of

recommendation by age for children on PD was different from the other three groups
(data not shown).
Nutrient Intakes from Average of 3-Day Dietary Records
Table 14 shows the nutrient intakes of the four groups based on the average of 3day dietary records. Different from the 24-hour diet recall records, energy (kcal) and
calories from fat were similar among treatment groups; whereas, only the intake of total
SAT and energy from SAT (kcal) differed among the treatment groups. As reflected in the
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24-hour diet recall records, average of 3-day dietary records also showed that SAT
calories (kcal) and SAT (grams) were lower in children on HD and PD as compared to the
pre-dialysis children, but intakes of children on PD and post-transplant children were
similar. No statistical differences were detected on analysis of the 3-day dietary records
for monounsaturated fat (MUFA) intake and trans fat intake; while, the difference in
polyunsaturated fat (PUFA) intake failed to reach significant difference (p=0.076).
Statistically significant findings on analysis of the 3-day dietary records showed
that Ca intake (p= 0.003) and phosphorus intake (p=0.017) differed among treatment
groups. Calcium intake, same as in the 24-hour dietary recall, was significantly lower in
the HD groups than the other treatment groups. Phosphorus intake was also lower in the
HD group compared to PD and post-transplant groups but were similar to the pre-dialysis
group.

Magnesium intake among the four groups of children missed statistical

significance (p = 0.071). Average 3-day antioxidant plus w-3 FA intake were significantly
different among the four treatment groups. The PD group had significantly higher intake
than the pre-dialysis and HD groups but not different from the post-transplant group. The
average total antioxidant intake showed similar pattern and approached to be statistically
significant.
Percent Recommended Nutrient Intakes from Average of 3-Day Dietary Records
Table 15 lists the percent recommended nutrient intakes of the four groups based
on 3-day dietary records averages. Three-day averages for SAT, protein, MUFA, and
PUFA intake varied significantly among treatment groups. PUFA intake and MUFA intake
were higher among children on PD and similar among the other treatment groups. SAT
fat intakes intake were lower in children on HD than that of children pre-dialysis but not
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different from the other two groups. Calcium intake was lower in the children on HD
although the difference failed to reach statistical significance.
Energy and macronutrient intakes from 24-hour diet recall and 3-day dietary
records were also analyzed based on CKD stages 3 to 5 and post-transplant children.
Figure 2 shows the energy, CHO, fat and protein intakes as percent of recommendations
based on 24-hour diet recall (top panel) and 3-day dietary records (lower panel).
Significant differences in energy and fat intakes were observed on the 24-hour diet recall
records. Energy intake was similar among stages 3, 4 and post-transplant children but
significantly lower in stage 5 children compared to stage 4 and post-transplant children.
Fat intake was similarly higher in stage 4 and post-transplant children and low in stage 5.
Carbohydrate intakes were lower and protein intakes were higher than the percent of
recommendations but did not differ among the four groups. No difference was observed
among CKD stages 3 to 5 and post-transplant children when 3-day dietary records were
analyzed.
There were no differences in bone-health related nutrients: Ca, vitamin D, and P
or in antioxidants: vitamins A, C, E and selenium based on the stages of CKD (Figure 3)
or among the four treatment groups (data not shown). Vitamin D intakes of children in
stages 4 and 5 were below 25% of the recommended daily intake. Daily Ca intake based
on 24-hour recall and expressed as a percent of recommended intake showed a
significant difference. Younger children (4-8 years) had significantly higher intake than
children in the 9-13 year and older than the 14-year age groups (95±17%, 48±9% and
48±8%, respectively, p=0.006). The older children had Ca intake less than half of the
recommended amount.
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Relationship between dietary intake and clinical measures (Table 16)
All Children: Based on the 24-hour diet recall and 3-day dietary records, dietary
total energy was negatively correlated with serum BUN, creatinine, Ca, Mg, and P.
Dietary protein intake was reversely related with serum BUN, and Mg. Carbohydrate
intake was inversely correlated with creatinine and serum P. Increase in total fat intake
was associated with reductions in serum albumin, BUN, creatinine, and HDL-C, but with
an increase in LDL-C. SAT intake was inversely correlated with DBP, BUN, creatinine,
Ca, P, and HDL-C, and positively correlated with LDL-C. Intake of MUFA was positively
associated with serum Fe and PTH but negatively with albumin. The positive correlation
between MUFA and serum K failed to reach statistical significance. Increase in PUFA
intake was positively correlated with PTH and LDL-C but inversely with albumin and
serum Fe. Omega-3 FA intake was positively related to TC, TG, LDL-C and 8-ISOP while
w-6 intake was associated with SBP, TC, and LDL-C. Increase in trans fatty acid intake
reduced serum Fe. Increase in dietary cholesterol intake increased SBP, Hgb, PTH but
reduced serum Mg and ABTS. Vitamin C was positively correlated with serum Ca and
vitamin D was negatively correlated with serum K. Vitamin E intake was positively
correlated with serum Fe, Mg and PTH. Dietary Ca intake was inversely correlated with
SBP, DBP, BUN, creatinine, Mg, P, and LDL-C. Dietary Na intake was negatively related
to BUN, creatinine, Ca, and Mg, but positively correlated with serum Na. Intake of K
reduced serum Mg while intake of Mg was positively associated with serum Fe. Dietary
Se increased SBP and serum Fe.
Total antioxidant intake and antioxidant plus w-3 FAs intake from both 24-hour
dietary recall and 3-day dietary records showed positive relationship with serum Fe. No
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relationship between antioxidant intake with or without adding w-3 FAs and other blood
parameters were observed, although total antioxidant intake (3-day dietary records)
showed a negative trend with TBARS concentrations.
Dialysis: Higher caloric intake reduced serum K, TBARS, and increase adequacy
of dialysis per Kt/V.

Protein intake was inversely related to albumin and BUN but

positively correlated with serum P. Increased CHO intake reduced creatinine, serum K
and TBARS. Total fat intake was negatively associated with albumin and BUN but
positively related to PTH. Higher SAT intake increased albumin. MUFA increased serum
Fe and PTH. Intake of PUFA was negatively correlated albumin but positively with serum
Fe, PTH, and Kt/V. Both w-3 and w-6 FAs were inversely related to serum Mg. Dietary
cholesterol was inversely related to serum Mg but positively with serum P. Vitamin C
intake reduced serum K and increased adequacy of dialysis per Kt/V, while vitamin E
intake increased serum Fe and PTH. Increase in Ca intake reduced creatinine, but
increased serum Fe and Kt/V. Increase in P intake positively correlated with serum P but
negatively correlated with serum albumin levels. Intake of K reduced albumin and serum
Mg. Increase in Mg intake reduced albumin but increased PTH. Dietary Se intake
increase albumin and serum P but reduced BUN.
Total antioxidant intake in the dialysis children was positively related to serum Fe
and Kt/V but negatively related to BUN. Increased intake of total antioxidant plus w-3 FAs
increased serum Fe and Kt/V. Intake of antioxidant plus w-3 FAs also reduced SBP
significantly, and BUN and creatinine non-significantly based on either set of dietary
intake data.
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Non-dialysis: Total energy intake was positively correlated with serum K but
negatively with serum Ca. Increased protein intake reduced SBP but increased serum
Fe. Higher CHO intake increased serum K but lowered TBARS. Total fat intake was
reversely correlated with serum Ca. SAT intake was inversely related to albumin and
serum Ca, although missed statistical significance with GFR. Omega-3 FA intake was
positively associated with Hgb, TG and LDL-C while w-6 FA intake increased TG, LDL-C
and TC/HDL-C. Trans fatty acid intake increased DBP and reduced serum Fe. Total
cholesterol intake elevated SBP and Hgb levels.

Increased vitamin A intake was

associated with higher SBP, creatinine and serum Fe. Dietary carotene intake was
positively correlated with SBP, creatinine, serum Fe but negatively with serum P. Vitamin
C intake increased SBP and serum Ca. Higher vitamin D intake lowered serum K while
higher vitamin E intake increased serum Mg and P. Dietary Ca intake was negatively
correlated with SBP, DBP, albumin, TC, LDL-C and TC/HDL-C levels. Dietary P and
serum Fe were negatively correlated. Dietary Na intake was associated with higher SBP
and serum Na and lower GFR. Dietary Se was positively correlated with Hgb.
Antioxidant intake was associated with SBP and creatinine and inversely related
to TBARS and GFR, although both missed statistical significance. Total antioxidant plus
w-3 FAs was positively related to SBP.
antioxidant z-score improved Hgb levels.

Adding w-3 fatty acid intakes to the total
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Renal Metabolic Profile
The results for GFR in the non-dialysis group and Kt/V in the dialysis are compared
with nutrient intakes as shown in Table 16. In the dialysis group, Kt/V correlated with an
increase in caloric intake, PUFAs, vitamin C, Ca, antioxidants, and antioxidants plus w-3
FA intake. In the non-dialysis group, dietary intakes of SAT, Na, and antioxidants showed
negative trends with GFR. Dietary sodium intake correlated with serum Na levels and
SPB and was inversely correlated with GFR.
Bone health-related nutrients based on antioxidants with or without w-3 FAs
Intakes of bone-health-related nutrients (vitamin D, Ca, P, K, Mg and protein) were
analyzed based on the categories of antioxidant and antioxidant plus w-3 FA intakes.
Antioxidant as well as antioxidant plus w-3 FA were divided into three equal groups, the
lowest one-third, the middle one-third, and the highest one-third. The results are shown
in Table 17. Children with higher antioxidant intakes with or without added w-3 FA intakes
were also consuming more Ca, P, K, Mg and protein (total and per kilogram of body
weight). Total antioxidant intake was also negatively correlated with blood TG levels but
failed to be significant (r=-.37, p=0.08).
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CHAPTER 4: DISCUSSION
To the best of our knowledge, this was the first clinical study that was uniquely
involved in researching the dietary effects of antioxidants and w-3 FAs on “disease
progressive oxidative stress” in children at various stages of CKD. In addition to the
dietary effects of antioxidant and w-3 fatty acids, our study compared nutrient intakes with
clinical measures at various stages of CKD. Since free radical damage begins well before
treatment with dialysis, variations in the children pre-dialysis compared to the children on
dialysis (HD and PD) and children post-transplant were examined.
Overall Objective
The purpose of this study was to understand the relationship between dietary
intake of antioxidants and w-3 fatty acids on free radical injury and free radical scavenging
in children with CKD so that complications of kidney failure, especially cardiovascular
disease, may be avoided or delayed.
Specific Aim #1
We tested the hypothesis that high dietary intake of antioxidants and w-3 FAs
would lower free radical damage, as measured by lipid peroxidation products (8isoprostanes & TBARS) in children with chronic kidney disease pre-dialysis, during
treatment with dialysis (HD and PD), and post renal transplantation.
Our findings showed protective effects of antioxidant plus w-3 FAs in the dialysis
and non-dialysis groups. In the non-dialysis group, adding w-3 FAs to antioxidant intake
intake improved Hgb levels. In children on dialysis, higher antioxidant intake with w-3
FAs improved dialysis outcome, as indicated by higher Kt/V values, reduced SBP, and
increased serum Fe levels. However, our findings of children in various stages of CKD
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did not support our hypothesis that dietary intake of antioxidants and w-3 FA intake would
lower free radical damage, although there was a trend toward reducing free radical injury
(TBARS).
Patients with CKD are known to have higher oxidative stress (Elshamaa et al,
2009; Lilien et al, 2005) due to dialysis products/process. Hence, higher antioxidant
intake may be beneficial for these dialysis patients. One possible explanation for our
negative result with 8-ISOP and slight correlation with TBARS is that oxidative products
other than the ones used in this study may be more effective to test for free radical injury
in patients with renal disease. Future studies to measure other oxidative products, such
as advanced oxidation protein products (AOPP) or analyzing several oxidative stress
products together may shed more light on the effects of antioxidant intake and oxidative
stress status in children with CKD.
It should be noted that children on HD had lower intake of antioxidants and
antioxidants plus w-3 FAs while children on PD had the highest levels. We did not
measure these children’s appetite or general feeling of well-being, however children in
the HD treatment group had lowest energy intake (24-hr recall) and the low antioxidant
intakes may be a result of low food intake in these children. On the other hand, children
in the PD group had similar energy intake as the post-transplant children but significantly
higher antioxidant intake. Hence, quality of the diet of these children played a role in the
amount of antioxidants consumed. Our results also showed that children with higher
antioxidant intake also had significantly higher total protein intake as well as protein intake
based on body weight, and these intakes were significantly higher than the
recommendations. While increased antioxidant intake has health benefits for the CKD
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children, increased protein intake above the amount required for optimal growth should
be discouraged. These results demonstrated the importance of including a registered
dietitian in the pediatric renal management team to educate the children and their
caregivers regarding how to consume enough protein for growth but not too much to put
an extra burden on the diseased or newly transplanted kidneys.
The current results showed the importance of antioxidant intake but also the need
for further large-scale study to validate the current findings. Our study also revealed the
relationships of antioxidant and w-3 FAs intakes with other important nutrients in children
with CKD.

Results from previous studies in this area are mixed.

A single-blind,

randomized, placebo-controlled study of 22 adult renal transplant patients, receiving 6
grams/day of w-3 FA supplementation orally for 6 months, actually found an increase in
oxidative stress as measured by 8-ISOP levels (Ramezani, Nazemian, Shamsara,
Koohrokhi, & Mohammadpour, 2011). Their study also found that w-3 supplementation
significantly reduced serum cholesterol levels in renal transplant children (Ramezani et
al., 2011).
In our study, no relationship was found between dietary intake of w-3 FAs and 8ISOP levels; although, all four groups that we studied had similar w-3 FAs intake and all
four groups were below 35% of the recommended daily intake for w-3 FAs. Omega-3 FAs
intake correlated with TC, TG, and TC/HDL-C levels. As previously stated, w-3 FAs
supplementation was shown to benefit children on HD dialysis by having a favorable
effect on lipid profiles and C-reactive protein levels (Daud et al., 2012). Our study was
different from the study conducted by Daud et al. in that w-3 FA supplements were not
administered, and all children in our study had low w-3 FAs intakes. Thus, it is possible
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that w-3 FAs supplement above the dietary level would benefit the CKD children in blood
lipid levels. When the intake of w-3 FAs is low, no such beneficial effects of w-3 FAs
could be observed.
In all children and in children not on dialysis, 8-ISOP had strong positive
correlations with TC, TG and LDL-C and a negative correlation with HDL-C. Similarly,
TBARS showed a positive correlation with TC and a weak correlation with TG. Even
though the casual relationship between dyslipidemia and elevated oxidative stress
products cannot be established in children with CKD, the mechanisms of this relationship
between the two parameters deserves further investigation. Dyslipidemia is a common
co-morbidity among children with CKD (Khurana & Silverstein, 2015). The administration
of statins may be indicated to improve the lipid profiles and offset oxidative damage. A
recent, three year randomized, placebo-controlled, double-blind study of 91 children with
autosomal dominant polycystic kidney disease was conducted to determine the effects of
pravastatin on plasma biomarkers for inflammation and oxidative stress (Klawitter et al.,
2015). From findings of this study the authors concluded: “Pravastatin therapy diminished
the increase of cyclooxygenase- and lipoxygenase- derived lipid mediators.” (Klawitter et
al., 2015, p. 1543). Statins are the only lipid-lowering drug classification approved by the
U.S. Food and Drug Administration (FDA) for use in children (Khurana & Silverstein,
2015), and our results support the use of statin drugs to lower the lipid levels in children
with CKD. This lipid lowering may indirectly reduce oxidative stress in these children.
Moreover, cardioprotective and renal protective nutritional measures for children
with CKD may include improving the balance between w-3 fatty and w-6 fatty acids.
Higher intakes of w-6 fatty acids may promote inflammation (Ehrlich, 2015). The w-6 FA,

39

arachidonic acid, produces inflammatory cytokines (Efstratiadis, Konstantinou, Chytas, &
Vergoulas, 2008; Noori et al., 2011). In our current study, higher intakes of both w-6 and
w-3 FAs increased blood lipid levels but high intakes of w-6 FAs also elevated systolic
blood pressure. Hence, w-6 FAs play a more important role in determining blood pressure
than w-3 FAs. The usual dietary intake of w-6 fatty acids is 14 to 25 times higher than w3 FA intake (Ehrlich, 2015). A preferred ratio of w-6 to w-3 is 2:1 to 4:1 or lower (Ehrlich,
2015). In our current study, the w-6 to w-3 ratio was around 9:1 (range: 8-11 to 1) for
both 24-hour recall and 3-day diary records. It is apparent that children with CKD need
to reduce the intake of w-6 fatty acids. Research conducted by Noori et al. (2011)
included the collection of three-day diet diary and diary interviews from 145 hemodialysis
patients for six months and were followed over 6 years. They reported that a higher
mortality rate and inflammation (higher CRP levels) were related to higher w-6 to w-3 fatty
acid ratio (Noori et al., 2011). Reducing intake of red meat, especially grain fed beef,
safflower, sesame, soy, sunflower, and corn oil and increasing intake of fatty fish,
including salmon, mackerel, and tuna will improve the balance of w-3 fatty and w-6 fatty
acids (Ehrlich, 2015).
BUN levels correlated with TBARS in the pre-dialysis group. No studies were
published showing a relationship between BUN and TBARS in CKD children, although a
study of 51 dementia patients and 30 control patients showed a correlation between
increased MDA levels and increased serum BUN levels in dementia patients (Chaturvedi,
2015). In order to design an effective dietary management plan for children with CKD, a
well-controlled large-scale study is needed to investigate the relationship between BUN
and blood TBARS levels.
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Specific Aim #2
We tested the hypothesis that high dietary intake of antioxidants and w-3 FAs
would produce better radical scavenging ability, as measured by ABTS levels in children
with chronic kidney disease pre-dialysis, during treatment with dialysis (HD and PD), and
post renal transplantation.
While dietary intake of antioxidants and w-3 FAs failed to demonstrate free radical
scavenging ability as measured by ABTS levels, other clinical measures that had a strong
positive correlation with ABTS included serum albumin (dialysis group), BUN (all children
and non-dialysis group), K (all children and non-dialysis group), Ca (all children) and P
(non-dialysis group) did show relationships. In addition to supporting growth, albumin has
been shown to have antioxidant potential.

Albumin bound bilirubin (Alb-BR)

demonstrated free radical scavenging in the plasma and extravascular tissue but was
less effective than the antioxidant vitamin C (Stocker, Glazer, & Ames, 1987). Results
from our study demonstrated that for all the children together, lower intakes of total fat,
MUFA and PUFA (from 3-day dietary records) may increase albumin levels, hence may
indirectly elevate antioxidant potential. It should be noted that this dietary manipulation
is also the dietary recommendation to reduce the risk of CVD, a co-morbidity of CKD.
However, for children on dialysis, reducing protein, total fat, and PUFA intake while
increasing the consumption of SAT may increase albumin levels and may have more
favorable outcomes. For post-transplant children, reducing SAT intake should be
encouraged.

Thus, the recommendation for fat intake should be based on the

stages/treatment of CKD. Reduced total fat and SAT intake also elevated serum Ca levels
in post-transplant children, which in term may increase albumin levels and free radical
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scavenging potential. For post-transplant patients, it has been reported that they tend to
lose phosphorus (Sakhaee, 2010). Since a positive correlation between serum P and
ABTS levels was observed in this group, increase intake of P in post-transplant children
may be indicated, not only to improve serum P status, but also to improve the free radical
scavenging. BUN and renal profile 2 demonstrated potential for free radical scavenging
as measured by ABTS assays in non-dialysis children. Whether this positive relationship
between renal profile 2 and ABTS was due to the fact that higher amounts of free radical
scavenging was required when the renal waste products were high deserves further
investigation.
Specific Aim #3
We tested the hypothesis that children with CKD and high dietary intake of
antioxidants and w-3 FAs would have a better metabolic profile and bone health as
compared to those with lower intake of these nutrients. Our results supported this
hypothesis.
Bone health, or strong bones and teeth, is supported by diet including vitamins,
minerals, and hormones which will lessen the risk of osteoporosis and fractures in
children with CKD. To determine bone health, we measured physiological parameters
including serum parathyroid hormone, hemoglobin, and phosphorus levels. Bone health
also included analysis of dietary intake of Ca, P, and vitamin D, although vitamin D3
supplementation and phosphate binders were not the focus of this study.
Growth retardation affects longitudinal bone growth at the epiphyseal growth plate
and is common in children with CKD, stages 3 to 5 (Bao & Chen, 2016; Kuizon & Salusky,
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1999).

Growth retardation results from poor appetite, malnutrition, anemia, and

hypoalbuminemia (Efstratiadis et al., 2008).
Clinical practice guidelines set forth by the KDOQI from the National Kidney
Foundation, identified that growth is “adversely affected by renal osteodystrophy”
("KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update,"
2009). Renal osteodystrophy is now termed chronic kidney disease – mineral and bone
disorder (CKD-MBD) (Isakova et al., 2017). CKD-MBD is seen in both children and adults
(Khouzam & Wesseling-Perry, 2017; Liu et al., 2015; Ray et al., 2017) and results in CKDmediated vascular calcification and CVD (Hruska, Sugatani, Agapova, & Fang, 2017;
Isakova et al., 2017; Khouzam & Wesseling-Perry, 2017).
According to Khouzam & Wesseling-Perry (2017), pediatric CVD begins before the
development of secondary hyperparathyroidism and is related to impaired mineral and
bone metabolism. Vitamin D along with PTH, from the parathyroid gland, and calcitonin
hormone, from the thyroid gland, regulates Ca metabolism which is important for bone
heath. Moreover, factors that inhibit Ca absorption include high P intake, vitamin D
deficiency, lack of stomach acids, as well as phytates (from nuts, seeds and grains) and
oxalates (from beet greens, spinach, and sweet potatoes) in the diet (Whitney & Rolfes,
2008). New KDOQI clinical practice guidelines recommend bone mineral density testing,
joint assessment, and counseling regarding phosphate intake, including dietary measures
and the administration of medications (Isakova et al., 2017).
From our findings in all children, there was a positive correlation with PTH and
serum phosphorus levels. Normally, the PTH increases serum Ca levels by Ca
reabsorption and P elimination via the kidneys (Whitney & Rolfes, 2008). Impaired kidney
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function alters this mechanism resulting in elevated P levels in blood and induces
secondary hyperparathyroidism.

Figure 4 shows the pathogenesis of secondary

hyperparathyroidism (http://www0.sun.ac.za/aotc/general/renal/rod.png).
In the current study, the PD group had significantly lower HGB levels than the predialysis and post-transplant groups but not different from the HD group. The two dialysis
groups also had significantly higher PTH levels. Furthermore, Hgb was also correlated
negatively with PTH levels. These observed metabolic changes may result in impaired
growth in children with CKD that were enrolled in this study.
The kidneys regulate erythropoietin which is responsible for the production of red
blood cells in the body. With the progression of CKD, Hgb levels decrease leading to
anemia as a result of decreased erythropoietin levels (Efstratiadis et al., 2008). Anemia
is integral to the triad called the “cardio-renal anemia syndrome” (Efstratiadis et al., 2008).
Anemia increases the risk of death by CVD in children with CKD (Efstratiadis et al., 2008).
In our study, we found a strong reverse correlation between Hgb and serum PTH levels
in all children and among children on dialysis. A previous study of 80 middle age and
elderly adults with CKD found a weak reverse correlation between Hgb and serum PTH
levels (Adhikary, Pokhrel, Yadava, Khadka, & Thakur, 2015). Approximately 70% of the
body’s iron is stored in the Hgb (Gupta, 2014). Interestingly, our finding for serum PTH
were positively correlated with serum Fe levels, and serum Fe was negatively correlation
with Hgb. These findings implied that decreased erythropoietin levels in dialysis children
resulted in reduced Hgb production and Fe not incorporated into Hgb resulting in elevated
blood Fe levels.
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Among all children and children on dialysis, we found a reverse correlation with
PTH and serum albumin levels as well. As stated previously, serum albumin levels reflect
protein status, affect overall growth, and have antioxidant potential. Moreover, Ca levels
may also be affected by increased dietary Na intake even though Na intakes in this study
were within the recommended amount. When Na intake is increased, both Na and Ca
are excreted resulting in low blood Ca levels (Whitney & Rolfes, 2008). The loss of Ca
affects skeletal growth and dental formation in children.
In our study of bone health nutrients (Ca, P, and vitamin D), we found that children
with higher total antioxidant intakes (vitamin A, b-carotene, vitamins C, E and selenium)
tended to have lower TG and TBARS concentrations.

A recent study using NMR

spectroscopy detected triglycerides in bone matrix (Mroue et al., 2016). This study
identified that triglycerides in bones may contribute to bone fractures and other diseases
(Mroue et al., 2016). No studies were found relating triglycerides to bone health in
children yet. However, our results demonstrated the possibility that increase antioxidant
intake had beneficial effects which may reduce TG deposition into the bones. Further
large-scale studies are warranted to explore the relationship between blood TG and TG
in bone matrix.
Adding w-3 fatty acid intakes to the antioxidant index improved Hgb levels in
children not on dialysis (pre-dialysis and post-transplant patients). As stated previously,
anemia is a contributing factor for increased lipid peroxidation and increases the risk of
death by CVD in children with CKD. Thus, prompt treatment of anemia in children with
CKD and post renal transplantation is indicated to reduce free radical injury, delay disease
progression, and reduce the risk of CVD.
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Total

energy

and

macronutrient

intakes

were

analyzed

according

to

recommendations for age and for differences among stages of CKD. Total energy and
macronutrient intakes less than 75% and more than 200% of the recommendations for
age were considered as inadequate. Energy, CHO, and fat intakes were all in the
adequate intake range even though there was a significant difference in energy and fat
intakes among children in different stages of CKD. Children on dialysis in stage 5 of CKD
had significantly lower total energy (kcal/day) and fat intake per day. CHO intakes were
lower and protein intakes were higher than the percent recommended but did not differ
among the four groups. However, protein intakes of children post-transplant and in CKD
stages 4 and 5 were higher than 200% of the recommendations. This high protein intake
may add an extra burden on the kidneys (diseased or transplanted) and should be
discouraged. Renal dietitians should emphasize more reduction of protein intake for
these children with CKD.
Other studies in children with renal disease found similar findings. A nutritional
assessment study of 30 children with CKD showed that actual energy and protein intakes
were 86.5% and 127% of the recommendations, respectively

(Apostolou, Printza,

Karagiozoglou-Lampoudi, Dotis, & Papachristou, 2014). Another study found that caloric
intake was less than 80% while protein intake was 150% of the RDA (Foreman et al.,
1996).
Energy and protein requirements for children post-transplant should be the same
as normal children (Rees & Shaw, 2007). Caution must be taken to prevent obesity in
children post-transplantation since 13% of recipients may become obese due to an
increased appetite secondary to steroid use (Rees & Shaw, 2007). In the current study,
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40% (6/15) of the post-transplant children were overweight (2/15, 13.3%) or obese (4/15,
26.7%), higher than that reported by Rees and Shaw (2007). Therefore, a top priority for
nutrition counseling in children post renal transplant should include instructions to
consume a nutrient-dense diet to obtain adequate nutrients for growth but not excess
energy to compromise weight.
In the pre-dialysis group, we found that worsening renal function was associated
with lower Hgb levels and increased free radical injury (8-ISOP and TBARS). Total
antioxidant intake plus w-3 FAs was found to improve Hgb levels in non-dialysis group.
From these findings, it is apparent that increased dietary antioxidant plus w-3 FA intake
helps to increase blood Hgb levels and may reduce free radical injury in children with
CKD. TBARS also positively correlated with TC and LDL-C in the non-dialysis group.
Increased dietary intake of Na was shown to decreased kidney function (GFR) in
the non-dialysis group. Dietary Na intake correlated with serum Na levels in the nondialysis group; and serum Na levels nearly correlated with SBP in the pre-dialysis group.
Dietary Na intake and serum Na levels should be closely monitored for all children,
especially children pre-dialysis to help maintain kidney function, reduce blood pressure,
and decrease the risk of CVD.
In children on dialysis, we found that vitamin C intake was shown to decrease
serum K levels and vitamin E intake was shown improve serum Fe levels. Moreover,
increased SBP and creatinine levels decreased adequacy of dialysis, while increased
Hgb had a non-significant reduction in Kt/V. We also found that higher caloric intake,
increase dietary intakes of Ca, vitamin C, PUFAs, antioxidants and antioxidants with w3FAs improved adequacy of dialysis, thus better renal functioning.

The positive
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relationships for PTH, TC, and TGs with adequacy of dialysis remains unclear. In all
children and especially in children on dialysis, higher intakes of quality nutrients, such as
foods higher in antioxidants (vitamins A, b-carotene, vitamins C, E and selenium) will help
improve kidney function by decreasing BUN and creatinine levels, as well as improve the
outcome of dialysis. Therefore, the importance of healthy nutrient intake cannot be overemphasized. Children on dialysis are also more vulnerable to oxidative stress due to the
iatrogenic effects of dialysis. Consequently, children and young adults on dialysis have a
higher mortality from CVD than that the general population (Himmelfarb et al., 2002).
In our study, we found that the w-6 to w-3 FA ratio was 9:1 where ideally, the ratio
should be 2:1 to 4:1 (Ehrlich, 2015). Moreover, we found that the dietary intake of w-3
FAs was very low with children consuming only 35% of the recommended daily intake.
However, this low intake of w-3 FAs showed a positive correlation with TC, TG, and
TC/HDL-C levels. Omega-3 FAs are reported to improve lipid profile levels. (Okreglicka,
2015).

Furthermore, w-3 FAs have renal protective and cardioprotective effects by

reducing pro-inflammatory cytokines and leukocyte adhesion molecules (Okreglicka,
2015). It is not clear why the results from our study were not in agreement with previous
findings and this deserves further investigation. It will be interesting to investigate if w-3
FA supplements to raise blood w-3 FA levels will improve the blood lipid profile in children
with CKD.
Saturated fats and trans fatty acids when consumed in excess increase TC and
LDL-C (Okreglicka, 2015). Trans fat intake in our study had a positive correlation with
DBP, another contributing factor to the development of CVD in children with CKD. Since
the kidneys play a major role in regulating blood pressure, reducing the intake of
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processed foods is advisable for two reasons.

First, processed foods are low in

antioxidant nutrients, such as vitamin C and high in w-6 FAs, saturated fats, and trans
fatty acids. Omega-6 FAs, and trans fatty acids are known to cause systemic inflammation
which is an underlying cause of cardiovascular disease (Calder, 2015; Noori et al., 2011;
Okreglicka, 2015). Second, processed foods are high in sodium. Even though sodium
intake among all age groups was within the recommended levels, a negative relationship
between dietary Na intake and GFR was observed, indicating higher Na intake (even
within recommended range) may impair kidney function in non-dialysis children.
Furthermore, increased dietary sodium intake not only increases blood pressure but also
causes the excretion of sodium and calcium (Whitney & Rolfes, 2008). Calcium loss
affects bone growth, and when calcium is displaced from the bones, calcification in the
vasculature of the heart contributes to CVD in children with ESRD (Chan, Lee, But, &
Chau, 2013)
In our study, we found that saturated fat intake was higher in the pre-dialysis and
post-transplant groups. Saturated fats also reduced albumin, Ca and the GFR in nondialysis children whose SAT intake was higher than the recommended. Saturated fat
intake also promotes inflammation and increases the risk of CVD in patient with CKD
(Okreglicka, 2015). Thus, to preserve kidney function in pre-dialysis or post-transplant
children, reducing SAT intake should be a priority goal for nutritional management.
The results from the current study demonstrated that higher antioxidant intake
lowered TG levels. Reduced TG levels may decrease the risk of triglycerides being
incorporated into the bone matrix and help prevent fractures in children with CKD. This
finding warrants further investigation in pediatric CKD population. Lowering dietary Na
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intake will also improve bone health. High dietary Na intake decreases Ca absorption
which also increases the risk for fractures.
Specific antioxidant intakes that were found to be of interest in children on dialysis
were vitamin C and vitamin E. Since high serum K levels are known to cause cardiac
arrhythmias, we found that children on dialysis may benefit from higher intakes of vitamin
C to reduce this risk. Moreover, vitamin C helps to form the basement membrane of blood
vessels by Type IV collagen formation and functions as an antioxidant in free radical
scavenging (May & Harrison, 2013). For these reasons, vitamin C was found to be
cardioprotective in children on dialysis. Children enrolled in our study all had vitamin C
intake above the amount recommended thus was not a nutrient of concern.
Another well-known antioxidant which offers cardioprotective effects is vitamin E.
In addition to having anti-inflammatory and lipid lowering properties, vitamin E intake was
shown to improve serum Fe levels in children on dialysis.

Moreover, vitamin E

supplementation may be indicated when hemoglobin levels are low and PTH levels are
high. In addition, vitamin E may play a role in improving iron stores in hemoglobin (Jilani,
Azam, Moiz, Mehboobali, & Perwaiz Iqbal, 2015) and should be investigated in children
on dialysis. In the current study, pre-dialysis and PD groups had adequate vitamin E
intake while HD and post-transplant groups had vitamin E intake less than 50% of the
recommended amount. Although the difference in vitamin E intake among the four groups
was not statistically significant, children on HD treatment and post-transplant may benefit
from increased vitamin E intake.
In addition to antioxidants, our study showed that dietary Ca had health benefits in
children with CKD, especially in children post-transplant. In addition to improving bone
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health, increased dietary Ca intake also improved blood lipid profiles in children posttransplant. In children on dialysis, increased dietary Ca intake improved the adequacy of
dialysis. In children not on dialysis, increased dietary Ca intake reduced systolic and
diastolic blood pressure and improved blood lipid profiles. Reduction in dietary Na intake
is another nutrition strategy to improve blood pressure and prevent the risk of CVD in
children with CKD. These dietary management practices not only benefit adult renal
patients but are also applicable to the pediatric CKD population.
Limitations
Valuable information was derived from this study which may help children with
CKD in the future. Convenience sampling, at a single site clinic, limited our sample size,
especially when considering the subgroups within the pediatric CKD population. The
population for this study was selected because children with CKD are at extremely high
risk for developing cardiovascular disease and antioxidants and w-3 FAs intakes were
hypothesized to decrease free radical injury and improve free radical scavenging.
Moreover, determining the best nutritional strategies to help children with CKD delay or
avoid the onset of cardiovascular disease is of utmost importance. For bone health, we
did not collect data on the administration of supplements (vitamin D or calcium) and
medications (phosphate-binders). This data should be collected in the future studies.
Since this study only included children with CKD, the study results may not generalize to
the population at large. Children’s Hospital of Michigan – Specialty Center is in an urban
setting. CHMs Specialty Center was selected because of the comprehensive services
and quality medical care it provides to children with CKD. Urban centers tend to service
individuals of lower socioeconomic status and educational level. Furthermore, following
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instructions and relying on the accuracy of self-reporting information on dietary records
are challenges.

We attempted to control for these variables by offering thorough

instructions, providing a handout on portion sizes, and giving the child and
parents/caregivers measuring devices to aid in the accuracy of measuring and recording
food intake. Despite the study limitations outlined, we believe our study has reliable data
with important discoveries that will improve the health of children with CKD in the future.
Conclusion and Clinical Implications
Our study of children at various stages of CKD provides a physiological basis for
the understanding of relationships between clinical measures, antioxidant, w-3 FA and
other nutrient intakes, and free radical activity. The relationships between clinical
measures, nutrient intakes, and oxidative stress were explored.
Based on clinical measures, antioxidant intake, and free radical activity, we found
several physiological relationships in children with CKD. We discovered that TGs may
play a role in bone health and free radical activity. Moreover, we have shown that higher
intakes of antioxidants (vitamin A, b-carotene, vitamins C, E & selenium) may help to
improve kidney function and dialysis treatment outcomes.
Clinical measure that correlated with improved GFRs include lower serum Na, K,
Mg, TG and TC/HDL-C. Since serum TC levels alone did not affect the GFR, the role of
non-HDL particles were evaluated in relationship to kidney function. Remarkably, LDL-C
did not show a relationship with impaired kidney function in any group; although, we did
find that elevated serum TG levels reduced kidney function in children in the non-dialysis
group. Recommendations for measures to lower serum TG levels and raise HLD-C levels
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include limiting sugar intake and exercising daily. These measures will also improve
blood pressure control.
Children on dialysis with higher albumin levels had better free radical scavenging
ability. Better free radical scavenging ability was also associated with lower PTH levels
and lower TG levels. These findings together demonstrated the importance of lowering
blood TG levels in order to improve growth and bone health.
In children on dialysis, better caloric intake improved renal function. Thus, high
quality, nutrient-dense caloric foods should be encouraged. Also, higher dietary protein
intake was found to reduce serum albumin levels. Albumin is more than just a marker of
nutritional status, albumin is becoming a biomarker of disease. Ischemia modified albumin
is a novel biomarker for diseases associated with ischemia and oxidative stress, including
renal failure, CVD and stroke (Kumar & Subramanian, 2016). Another association with
albumin includes dietary intake of phosphorus. Dietary intake of P showed a positive
relationship with serum P levels and a negative relationship with serum albumin levels.
An elevated phosphorus and calcium product may not only contribute to the pathogenesis
of CVD but may also be a physiological mediator affecting disease and protein status in
children on dialysis. Therefore, dietary teaching should continue to emphasize the need
for high Ca and low P containing foods. Children on dialysis should be encouraged to
avoid foods with phosphorus additives, including soda beverages (sweetened and
artificially sweetened), and processed foods. Sugar sweetened beverages (SSB) and
dietary intake of P have been linked to obesity (Anderson, 2013; Bucher Della Torre,
Keller, Laure Depeyre, & Kruseman, 2016), a finding we observed in this study. Moreover,
SSB have been tied to hypertension (Malik, Akram, Shetty, Malik, & Yanchou Njike,
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2014). Thus, children on dialysis and all children with CKD should reduce or avoid intake
of soda beverages to help with weight and blood pressure control and slow the
progression of renal disease.
Children on dialysis should also limit foods high in phosphorus, such as meat,
dairy, and chocolate. In addition, a plant-based diet should be recommended to include
whole grain foods, legumes, nut and seeds because the bioavailability of phosphorus is
lower in plant than animal sources (NKF, 2017). Moreover, foods high in calcium and
calcium-containing phosphate medications are a continued recommendation by the
National Kidney Foundation.
In all children and in children in the non-dialysis group, free radical injury strongly
correlated with poor lipid profiles. Whereas, dietary calcium intake improved blood
pressure and lipid profiles. Thus, adequate dietary calcium intake should be encouraged.
In children on dialysis, vitamin C was found to be cardioprotective by decreasing K levels
and is well-known for its free radical scavenging abilities. Vitamin E, on the other hand,
improved Fe levels in children on dialysis and improved Hgb levels in the pre-dialysis
group. Therefore, adequate intakes of vitamins C and E should be strongly monitored
and encouraged.

The best food sources of vitamins C and E are fresh fruits and

vegetables, vegetable oils, nuts and seeds.
Antioxidants showed a non-significant negative relationship with TBARS but not
with other free radical activity or scavenging ability.

Nevertheless, antioxidants did

correlate with other clinical measures that may vary with free radical injury and free radical
scavenging biomarkers. Children on dialysis with higher intake of antioxidant intakes with
w-3 FAs had better dialysis outcome and control of SBP.
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It should be noted that in all groups of children, w-3 FA intake was below 35% of
the recommended daily intake and the w-6 to w-3 FA ratio was high at a ratio of 9:1.
Therefore, the need to increase w-3 FA intake is warranted in children with CKD to reduce
the w-6 to w-3 FA ratio. Also, the negative relationship between dietary intake of PUFAs
and serum albumin levels should be re-evaluated in children who are consuming at least
75% of the recommended daily intake of w-3 FAs before any further conclusions may be
drawn regarding protein and disease status and PUFA intake.
In all children, TC, TG, LDL-C and TC/HLD-C positively correlated with free radical
injury. In children on dialysis, free radical scavenging ability was reversely related to TC,
TG, TC/HDL-C. Thus, reducing dietary intake of cholesterol may decrease oxidative
stress and the administration of statin drugs may be indicated for children with CKD.
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Table 1: Age and treatment distribution of all children

Pre-dialysis
Age

Total

Hemodialysis Peritoneal
Dialysis

Post
Transplant

Total

1

5 (50%)

0 (0%)

2 (20%)

3 (30%)

10 (21.3%)

2

4 (20%)

4 (28.6%)

2 (14.3%)

4 (28.6%)

14 (29.8%)

3

3 (21.4%)

5 (35.7%)

1 (7.1%)

5 (35.7%)

14 (29.8)

4

3 (33.3%)

2 (22.2%)

1 (11.1%)

3 (33.3%)

9 (19.1%)

15 (32.6)

11 (23.4%)

6 (12.8%)

15 (32.6)

Ages: 1: younger than 6, n=10; 2: 7-12, n=14; 3: 12-18, n=14; 4: older than 18, n=9
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Table 2: Racial distribution of the children, n (percent)
Pre-dialysis Hemodialysis Peritoneal
Dialysis

Post
Transplant

Total

White

7 (41.2%)

1 (5.9%)

1 (5.9%)

8 (47.1%)

17 (36.2%)

AA

6 (25%)

10 (41.7%)

4 (16.7%)

4 (16.7%)

24 (51.1%)

Hispanic

0 (0%)

0 (0%)

1 (33.3%)

2 (66.7%)

3 (6.4%)

Asian/others 2 (66.7%)

0 (0%)

0 (0%)

1 (33.3%)

3 (6.4%)

Total

11 (23.4%)

6 (12.8%)

15 (31.9%)

15 (31.9%)

Abbreviation: AA, African American
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Table 3: BMI percentile, and Z-score (mean ± standard deviation) of the 4
treatment groups
Pre-dialysis Hemodialysis Peritoneal
Dialysis
(n=15)
(n=11)
(n=6)

Post-transplant

p

(n=15)

BMI percentile

75.8±24.5

53.8±41.2

59.6±29.5 (5) 67.1±28.0

ns

Z-score

1.04±1.1

.05±1.7

.31±.87

ns

Abbreviations: BMI, body mass index; ns, not significant

.62±1.0
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Table 4: Comparison of blood pressure (mmHg, mean±SEM) and recommended blood
pressure ranges by age

SBP

3.0-5.9 y

6.0-9.9 y

10.0-11.9 y

(n=6)

(n=7)

(n=10)

97.3±.3.9a

111.6±5.0ab

112.5±3.7bc

12.0-14.9 y
(n=5)
117.2±6.0be

> 15 y
(n=18)
127±3.5de

Range 80-108

102-138

99-129

100-134

Recommended
Range 89-112

97-115

102-120

110-131

120

56.4±7.6a

69.5±10.9c

73.0±14.0c

66.6±2.0c

DBP
Range

57.0±5.9a

p

<.0001

102-157

50-68

46-66

47-87

62-92

46-79

Recommended
Range 46-72

57-76

61-80

64-83

80

Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure

=.007
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Table 5: Hemoglobin (Hgb) levels (mg/dL) according to age categories
(mean±SEM)
Male
Female
< 6 years 7-12 years
12-18 years > 18 years > 18 y
(n=10)
(n=14)
(n=14)
(n=6)
(n=3)
Hgb

11.2±.7

Normal Hgb 12.5

p

11.1±.5 a

11.9±.5 a

12.2±..6 a

11.3±.3b =0.053

13.5

14.5

15.5

13.8

a: significantly differently from normal Hgb value at p<.0001
b: significantly different from normal Hgb value at p<.01
Abbreviation: Hgb, hemoglobin
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Table 6: Routine laboratory values for the 4 treatment groups (n) (mean±SEM)
Pre-dialysis HD

PD

Posttransplant
(n=15)

p

(n=15)

(n=11)

(n=6)

Hgb
(g/dL)

12.3±1.8ad

11.2±1.8ac

9.4±1.2bc

12.7±2.1ad

=.003

Albumin
(g/dL)

3.8±.4a (11) 3.7±.2a (10)

3.0±.5b

3.8±.3a (13) <.0001

BUN
(mg/dL)

33±15a

49±12b

54±15b

23±9c

<.0001

Creatinine
(mg/dL)

2.0±1.3a

11.2±2.3b

8.3±2.5c

1.0±.4a

<.0001

Ferritin
(ng/mL)

74±47a (11) 71±70a (10)

275±172b (4) --

=.001

Sodium
(mEq/L)

140±3

139±3

139±3

138±2

ns

Potassium
(mEq/L)

4.4±.4

4.3±.6

4.1±.6

3.9±.7

ns

Calcium
(mg/dL)

9.1±.6

9.7±1.1

9.4±1.0

9.1±.4

ns

Phosphorus
(mg/dL)

4.3±1.0a

6.0±1.9b (10) 5.9±1.5b

3.9±.7a

=.001

Magnesium
(mg/dL)

2.1±.3a

2.7±.2b (10)

1.7±.2c

<.0001

PTH
(pmol/L)

79±39a (6)

314±310a(10) 867±571b(5) 145 (1)

=.005

TC
(mg/dL)

231±50 (3)

163±8 (6)

184±22 (4)

171±16 (9)

ns

HDL-C
(mg/dL)

40±.9 (2)

62±3.7 (5)
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65±6 (5)

ns

LDL-C

128±99 (2)

--

--

82±12 (9)

ns

2.5±.7b
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(mg/dL)
TG
(mg/dL)

275±58a (3) 83±12bd (7) 216 ± 43a (3) 117±21cd (9) =.001

TC/HDL-C
(mg/dL)

5.3±2.1a (2) 2.6±.2b (5)

3.6 (1)

2.8±.3b (9)

=.044

Renal profile 2 z score
(BUN+creatinine) -.75±.27

na

na

-1.58±.14

<.0001

GRF

36.5±3.8

na

na

68.0±4.4

<.0001

Kt/V

na

1.75±.09

2.65±.25

na

=.001

Abbreviations: HD, hemodialysis; PD, peritoneal dialysis; Hgb, hemoglobin; BUN, blood
urea nitrogen, PTH, parathyroid hormone; TC, total cholesterol; HDL-C, high-density
lipoprotein cholesterol, LDL-C, low-density lipoprotein cholesterol; TG, triglycerides;
Renal prof 2, z score (BUN + creatinine); GFR, glomerular filtration rate; Kt/V =
adequacy of dialysis
--: No data
ns, not significant
na, not applicable
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Table 7: Comparisons of biomarkers for free radical injury (8-ISOP & TBARS) and
free radical scavenging (ABTS) in the 4 treatment groups (mean±SEM)
Pre-dialysis Hemodialysis Peritoneal
Dialysis
(n=15)
(n=11)
(n=6)

Posttransplant
(n=15)

p

8-ISOP
(pg/mL)

419±296 (15) 157±65 (11) 450±424 (6) 440±326 (15) =.069

TBARS
MDA (µM)

14.2±5.6

13.6±3.7

13.3±6.2

ABTS
Trolox (mM)

0.06±0.05a

0.08±0.03a

0.04±0.04ac 0.03±0.04bc =.015

17.2±5.3

Abbreviations: 8-ISOP, 8-Isoprostanes; TBARS, Thiobarbituric Acid Reactive
Substances; ABTS, 2,2’-Azino-di-[3-ethylbenzthiazoline sulphonate]
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Table 8: Relationships between clinical measures of the children
(Only significant correlations are shown)
All Children Pre-dialysis
(n=47)
SBP vs
DBP
Hgb
Albumin
BUN
Creatinine
Serum Fe
Serum Na
Serum Ca
Serum Mg
Kt/V

(n=15)

Dialysis
(n=17)

Posttransplant
(n=15)

Non-dialysisd
(n=30)

.54**
--------na

.53#
---.63*
-.49#
--.69**
na

----.51*
--.54*
----.49*

.71**
.57*
.69**
-.72**
---.51#
.62*
na

.63**
.41*
-------na

DBP vs
BUN
-Creatinine
.37*
Serum Ca
-ƒ
Renal prof 2
na

-.68**
----

---na

-.52*
-.65**
--

-.47**
---.40*

Hgb vs
Albumin
BUN
Creatinine
Serum Fe
Serum P
PTH
8-ISOP
Renal prof 2
Kt/V

.57**
-.49**
-.34*
-.44*
-.43**
-.69**
-na
na

-----.59*
---.59*
na

----.53*
--.73**
-.48*
na
-.42#

.66*
-------na

.56*
-.55**
---.41*
---.48**
na

Albumin vs
BUN
Creatinine
Serum Fe
Serum Ca
Serum Mg
PTH
TC
TG
LDL-C
TC/HDL
ABTS

.33*
-.33*
-.57**
---.63**
-.70**
-.59*
-.84*
-.75**
--

---.63**
.66*
--------

----.51*
-.59*
----.66**

---.64*
-.78**
-------

-------.85*
--.84*
-.85*
--
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BUN vs
Creatinine
Serum K
Serum Mg
Serum P
TBARS
ABTS
Renal prof 2
GFR

.59**
-.52**
.45**
-.34*
na
na

------.97**
--

----.64*
-na
na

------.99**
--

-.44*
-.42*
-.54**
.97**
-.60**

Creatinine vs
Serum Na
Serum K
Serum Mg
Serum P
TC
TG
LDL-C
TC/HDL
Renal prof 2
GFR
Kt/V

--.63**
.54**
--.95**
-na
na
na

.59*
-------.61*
-na

--------na
na
-.66*

--------.49#
-na

.54**
.44*
--.91**
.89**
.95**
.98**
.67**
-.80**
na

Serum Fe vs
Serum Mg
PTH
8-ISOP

.48*
.62**
--

----

.60*
-.56*

-.63*
--

----

Serum Na vs
K
Serum Ca
Serum Mg
Serum P
TC
TG
LDL-C
TC/HDL
GFR

------.80*
.79**
na

.52*
---------

--.59*
-.52*
----na

----------

--.39*
--.75#
.91**
.80*
.90**
-.44*

------

----na

.56*
.70**
----

---.36*
.49**

Serum K vs
Serum Mg
.36*
Serum P
-TG
.58*
ABTS
.30*
Renal prof 2
na
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GFR

na

--

na

--

-.43*

Serum Ca vs
Mg
TG
ABTS
GFR

.36*
-.68*
.34*
na

-----

---na

-----

---.35#

Serum Mg vs
P
HDL-C
TBARS
GFR

.40**
--.31*
na

-----

---na

-----

--.81*
--.44*

Serum P vs
PTH
TBARS
ABTS

.43*
---

----

----

-.60*
--

--.36*

Serum TC vs
Kt/V

na

na

.66*

na

na

Serum TG vs
Renal prof 2
GFR
Kt/V

na
na
na

--na

na
na
.89**

--na

.66*
-.74**
na

Serum HDL-C vs
GFR

na

--

na

--

.71*

Serum TC/HDL vs
GFR
na

--

na

--

-.75**

PTH vs
TG
TC/HDL-C
8-ISOP
ABTS
Kt/V

.76*
-.42#
-na

--.79#
-na

.93**
.91**
.56*
-.45#

----na

----.72#
na

na
na
na
na

-.53*
.65**
--

na
na
na
na

-----

.66*
--.49**

Renal prof 2 vs
TG
8-ISOP
TBARS
ABTS
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Statistical Significance: **: p<.01; *: p<.05; #:.10>p>.05; --: not significant
ƒ: renal profile 2, composite score (sum of z scores of BUN and creatinine)
d: pre-dialysis and post-transplant children
na, not applicable
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; Hgb,
hemoglobin; BUN, blood urea nitrogen; Fe, ferritin; Na, sodium; K, potassium; Ca,
calcium; Mg, magnesium; P, phosphorus; PTH, parathyroid hormone; TC, total
cholesterol; HDL-C, high-density lipoprotein cholesterol, LDL-C, low-density lipoprotein
cholesterol; TG, triglycerides; 8-ISOP, 8-Isoprostanes; TBARS, Thiobarbituric Acid
Reactive Substances; ABTS, 2,2’-Azino-di-[3-ethylbenzthiazoline sulphonate]; GFR,
glomerular filtration rate; Kt/V, adequacy of dialysis
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Table 9: Relationships between blood lipid levels and oxidative and scavenger
biomarkers
All children
(n=47)

Dialysis
(n=17)

Non-dialysis
(n=30)

8-ISOP vs
TC
TG
HDL-C
LDL-C
TC/HDL-C

-.68**
-.59**
-.61**

-.73*
-.73#
-.95**

-.65*
-.58*
-.64*

TBARS vs
TC
TG
HDL-C
LDL-C
TC/HDL-C

.63**
.40#
-.66*
--

------

.72**
--.66*
--

ABTS vs
TC
TG
HDL-C
LDL-C
TC/HDL-C

------

-.56#
-.62*
---.77#

------

Statistical Significance: **: p<.01; *: p<.05; #: .10>p>.05; --: not significant
Abbreviations: TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol, LDL-C,
low-density lipoprotein cholesterol; TG, triglycerides; 8-ISOP, 8-Isoprostanes; TBARS,
Thiobarbituric Acid Reactive Substances; ABTS, 2,2’-Azino-di-[3-ethylbenzthiazoline
sulphonate]
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Table 10: Nutrient intakes of the 4 treatment groups based on 24-hour recall (n)
(mean±SEM)
Pre-dialysis Hemodialysis Peritoneal
Dialysis

Posttransplant

Total

(n=15)

(n=15)

(n=47)

(n=11)

(n=6)

p

Energy (kcal) 2009±172a 1262±146b

1411±172bc 1932±168ac 1733±97

Protein (g)

70.2±5.5

52.7±6.9

57.7±9.4

75.0±9.4

66.0±4.1

ns

CHO (g)

246±24

162±31

202±38

229±26

215±15

ns

Fat (g)

81±9a

44±5b

42±12b

81±12a

68±6

=0.014

SAT (g)

23±3a

12±2b

8±2b

27±5a

20±2

=0.006

Fat %

35.7±2.4

33.1±3.1

27.0±5.5

36.7±3.7

34.3±1.7

ns

MUFA (g)

23±6

13±3

20±10

14±4

18±3

ns

PUFA (g)

11±3

8±1

9±3

8±2

9±1

ns

w-3 FA (g)

0.6±0.2

0.5±0.1

0.5±0.2

0.5±0.2

0.5±0.1

ns

w-6 FA (g)

5.0±1.3

5.4±1.1

4.7±2.0

4.5±1.7

4.9±0.8

ns

Chol (mg)

214±41

186±48

144±75

276±63

219±28

ns

Vit A (µg)

267±104

230±82

184±81

272±61

249±43

ns

Vit C (mg)

74±18

117±42

143±62

93±31

99±17

ns

Vit D (µg)

17.5±12.1

1.3±0.5 (10) 1.1±0.5

10.1±6.7

9.4±4.5 (46) ns

Vit E (mg)

7.6±3.2 (14) 3.2±1.5

9.9±6.9

4.4±1.7

5.8±1.5 (46) ns

Ca (mg)

869±133a

257±51bc

532±169ac

901±110a

694±71

=0.001

Na (mg)

3047±431a

1500±162b

1325±199b

3003±370a

2452±214

=0.003

Mg (mg)

152±25

77±13

141±26

149±38

132±16

ns

P (mg)

759±100

427±85

580±98

766±172

661±69

ns

=0.008
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K (mg)

1453±278

772±104

1222±292

1227±210

1192±122

ns

Iron (mg)

13±1.7

9±1.7

9±2.3

12±1.3

11±0.9

ns

Se (µg)

51±9.7

50±8.4

50±14.7

50±11.4

50±5.3

ns

Antioxidantsƒ -.14±.68

-.08±1.01

1.05±1.09

-.10±.60

.04±.39

ns

Antioxid+w-3 -.06±.73

-.17±1.04

1.06±1.00

-.11±.81

.04±.44

ns

ƒ: The sum of z scores of vitamin A, beta carotene, vitamin C, vitamin E and selenium
Abbreviations: CHO, carbohydrates; SAT, saturated fat; MUFA, monounsaturated fatty
acids; PUFA, polyunsaturated fatty acids; w-3 FA, omega-3 fatty acids; w-6 FA, omega-3
fatty acids; Chol, cholesterol; Vit, vitamin; Ca, calcium; Na, sodium; Mg, magnesium; P,
phosphorus; K, potassium; Se, selenium; Antioxid+w-3, antioxidants with omega-3 fatty
acid; ns, not significant
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Table 11: Protein intake (g/kg) based on age groups (mean±SEM) and
comparison with RDI
1–3y

4–8y

9 – 13 y

> 14 y

p

5.2
(n=1)

2.9±0.6a*
(n=6)

1.6±0.1b**
(n=6)

1.5±0.3b**
(n=9)

=.03

Protein intake from recall

3.2±1.3a**
(n=13)

1.4±0.8b*
(n=13)

1.1±0.6b*
<.001
(boys, n=14)
1.4±0.9*
(girls, n=6)

RDI (g/kg)

0.95

0.95

0.73 (boys)
0.71 (girls)

Ave protein intake (g/kg)

RDI: Reference Daily Intake
Numbers in the same row with different superscripts are significantly different from other
age groups
*: significantly different from RDI at p<0.05
**: significantly different from RDI at p<0.01
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Table 12: Sodium intake based on age distribution (mean±SEM) and comparison
with recommendation by age
1 – 3 years
(n = 1)

4-8 years
(n = 13)

9 – 13 years
(n = 13)

> 14 years p
(n = 20)

Sodium intake
(mg/day)

1066

2231±258

2307±491

2758±350

Recommendation

1500

1900

2200

2300

ns, not significant

ns
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Table 13: Percent recommended nutrient intakes of the four groups based on 24hour recall (n) (mean±SEM)
Pre-dialysis Hemodialysis Peritoneal
Dialysis

Posttransplant

Total

p

(n=15)

(n=11)

(n=6)

(n=15)

(n=47)

Energy

101±11

62±8

92±14

101±12

91±6

0.061

Protein

206±29

146±29

254±65

242±44

209±20

ns

CHO

88.3±9

58.6±10

93.7±18

87.1±12

81.6±6

ns

Fat

136.4±21

67.5±11

93.8±31

138.0±24

115±12

ns

SAT

121±17ac

55±9bd

54±12ad

139±30c

103±12

0.022

MUFA

117±29

64±20

127±68

68±20

90±15

ns

PUFA

53±11

42±6

60±21

38±9

46±5

ns

w-3 FA

27±8

25±4

35±14

25±9

27±4

ns

w-6 FA

26±6

30±4

35±16

25±9

28±4

ns

Chol

90±20 (9)

73±20 (8)

63±36 (4)

103±31 (9)

86±13 (30)

ns

Vit A

40±13

36±11

31±13

48±13

40±6

ns

Vit C

196±52

230±71

377±127

218±78

234±37

ns

Vit D

117±81

8±3 (10)

7±3

67±44

63±30 (46)

ns

Vit E

101±47 (14) 36±21

146±118

43±21

72±22 (46)

ns

Ca

80±13ac

20±4bd

57±23ade

81±11ce

63.34±7

0.003

Na

142±19

65±6

66±11

139±17

113±10

ns

Mg

80±16

31±8

90±37

64±16

65±9

ns

P

97±13

54±12

79±20

102±25

86±10

ns

K

34±6

19±2

29±6

28±5

28±3

ns
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Iron

137±18

87±23

100±38

123±13

116±10

ns

Se

134±27

120±22

149±52

118±24

127±14

ns

Abbreviations: CHO, carbohydrates; SAT, saturated fat; MUFA, monounsaturated fatty
acids; PUFA, polyunsaturated fatty acids; w-3 FA, omega-3 fatty acids; w-6 FA, omega-3
fatty acids; Chol, cholesterol; Vit, vitamin; Ca, calcium; Na, sodium; Mg, magnesium; P,
phosphorus; K, potassium; Se, selenium; ns, not significant
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Table 14: Nutrient intakes of the four groups based on 3-day dietary records
average records (n) (mean±SEM)
Pre-dialysis Hemodialysis Peritoneal
Dialysis
(n=9)
(n=5)
(n=3)

Posttransplant
(n=5)

Total

p

(n=22)

Energy (kcal) 1945±110

1536±176

1998±172

2222±398

1922±114

ns

Protein (g)

70±7

50±7

85±9

88±18

71±6

ns

CHO (g)

251±18

220±29

249±79

330±71

262±21

ns

Fat (g)

74±7

52±9

77±13

64±10

67±5

ns

SAT (g)

26±2.2a

16±3.4bc

16±4.0bd

20±2.2acd

21±1.6

=0.04

MUFA (g)

16.5±5.2

9.1±1.2

37.7±16.1

10.2±3.8

16.3±3.5

ns

PUFA (g)

6.8±1.8

8.5±0.7

14.7±1.4

6.2±2.4

8.1±1.1

ns

w-3 (g)

0.4±0.1

0.4±0.1

1.9±1.2

0.8±0.6

0.7±0.2

ns

w-6 (g)

3.6±0.5

3.6±0.7

6.9±3.5

3.4±1.2

4.0±0.6

ns

Cholest (mg) 196±29

151±45

191±110

304±120

209±34

ns

Vit A (µg)

719±234

253±200

551±282

378±148

512±118

ns

Vit C (mg)

98±22

96±42

202±112

142±57

122±23

ns

Vit D (µg)

5.9±4.0

3.4±1.5

1.9±0.6

12.2±5.9

6.2±2.2

ns

Vit E (mg)

6.7±3.1

1.9±0.7

18.4±12.9

5.6±2.4

6.9±2.3

ns

Ca (mg)

988±129a

305±45b

872±210a

936±247a

805±97

=.033

Na (mg)

2883±358

2227±520

1937±473

2826±445

2592±223

ns

Mg (mg)

130±16

70±27

222±12

176±63

139±19

ns

P (mg)

655±91ab

404±73a

1039±161bc 1044±223c

739±83

=.017

Pot (mg)

1381±148

820±178

1976±511

1400±151

ns

1668±429
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Iron (mg)

14±2

18±10

21±3

16±4

16±2

ns

Se (µg)

49±7

35±10

76±4

70±30

54±8

ns

Antioxidantsƒ .28±1.02

-2.47±.41

3.08±.63

.12±1.36

.00±.62

ns

Antioxid+w-3 .68±1.05a

-2.11±.38a

4.98±1.02bc .96±1.88ac

.69±.74

=.036

ƒ: The sum of z scores of vitamin A, beta carotene, vitamin C, vitamin E and selenium
Abbreviations: CHO, carbohydrates; SAT, saturated fat; MUFA, monounsaturated fatty
acids; PUFA, polyunsaturated fatty acids; w-3 FA, omega-3 fatty acids; w-6 FA, omega-3
fatty acids; Chol, cholesterol; Vit, vitamin; Ca, calcium; Mg, magnesium; P, phosphorus;
K, potassium; Se, selenium; Na, sodium; Antioxid+w-3, antioxidants with omega-3 fatty
acids; ns, not significant
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Table 15: Percent recommended nutrient intakes of the 4 treatment groups based
on 3-day dietary records average records (n) (mean±SEM)
Pre-dialysis Hemodialysis Peritoneal PostDialysis
transplant
(n=9)
(n=5)
(n=3)
(n=5)

Total

p

Energy

100±11

70±10

134±8

116±25

102±9

ns

Protein

214±35a

126±21a

390±79bc

267±76ac

230±29

0.042

CHO

95±13

75±14

119±34

127±32

101±11

ns

Fat

124±19

74±10

168±36

108±23

115±12

ns

SAT

131±12a

68±11bc

107±23ac

105±19ac

107±9

0.042

MUFA

85±33a

38±6a

238±112b

46±15a

86±23

0.043

PUFA

39±13a

40±5a

100±15b

32±14a

46±8

0.035

w-3 FA

21±4a

17±6a

122±79b

38±23a

38±13

0.053

w-6 FA

22±5

17±2

50±25

20±8

24±4

ns

Chol

73±14 (5)

55±25 (3)

91±43 (2)

111±72 (3)

80±18 (13)

ns

Vit A

135±55

42±33

79±40

57±17

89±25

ns

Vit C

274±89

286±191

463±177

297±99

308±62

ns

Vit D

39±27

23±10

13±4

81±39

41±15

ns

Vit E

87±46

16±6

270±233

41±15

86±37

ns

Ca

93±13a

26±5bc

99±34a

80±25 ac

75±10

0.059

Na

135±14

104±26

92±13

132±24

121±10

ns

Mg

71±16

27±9

134±67

71±24

70±13

ns

P

98±19

49±14

142±24

111±34

96±13

ns

K

32±3

18±4

46±7

38±9

32±3

ns

(n=22)
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Iron

157±30

208±127

181±46

164±36

173±31

ns

Se

128±23

80±18

219±81

158±55

136±20

ns

Abbreviations: CHO, carbohydrates; SAT, saturated fat; MUFA, monounsaturated fatty
acids; PUFA, polyunsaturated fatty acids; w-3 FA, omega-3 fatty acids; w-6 FA, omega-3
fatty acids; Chol, cholesterol; Vit, vitamin; Ca, calcium; Mg, magnesium; P, phosphorus;
K, potassium; Se, selenium; Na, sodium; ns, not significant
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Table 16: Relationship between dietary intake and clinical measures (24-h
recall/3-day dietary records) (Only significant relationships are shown)
All children
(n=47)

Dialysis
(n=17)

Non-dialysis
(n=30)

Total energy vs
BUN
Creatinine
Serum K
Serum Ca
Serum Mg
Serum P
TBARs
Kt/V

-.29*/--.44**/---/---/-.43*
-.31*/---/-.46*
--/-na

--/---/--.59*/---/---/---/---/-.86**
--/.65#

--/---/-.40*/---/-.62*
--/---/---/-na

Protein intake vs
SBP
Albumin
BUN
Serum Fe
Serum Mg
Serum P

--/---/--.35*/---/--.38**/---/--

--/---/-.86**
-.59*/---/---/-.55*/--

--/-.58*
--/---/---/.76*
--/---/--

CHO intake vs
Creatinine
Serum K
Serum P
TBARs

-.29*/---/---/-.47*
--/--

--/-.71*
-.69**/---/---/-.80*

--/-.42*/---/--.42*/--

Total fat vs
Albumin
BUN
Creatinine
Serum Ca
PTH
HDL-C
LDL-C

--/-.52*
-.30*/--.41**/---/---/---/-.89*
--/.92*

--/-.75*
--/-.76*
--/---/-.62*/---/---/--

--/---/---/---/-.76**
--/---/---/--

SAT vs
DBP
Albumin
BUN
Creatinine
Serum Ca
Serum p
HDL-C

--/-.48*
--/--.31*/--.43**/---/-.44*
-.35*/---/-.91*

--/-.57*/---/---/---/---/---/--

--/---/-.58*
--/---/---/-.63*
--/---/--
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LDL-C
GFR

--/.96**
na

--/-na

--/---/-.49#

MUFA vs
Albumin
Serum Fe
Serum K
PTH

--/-.48*
--/.84**
.26#/-.55/.88**

--/-.64*/.88**
--/-.64*/.96**

--/---/---/---/--

PUFA vs
Albumin
Serum Fe
PTH
LDL-C
Kt/V

--/-.53*
--/-.58*
.51*/.68*
.71**/-na

--/-.83*
--/.81*
.58*/.81**
--/---/.79*

--/---/---/---/-na

w-3 FA vs
HGB
Serum Mg
TC
TG
LDL-C
8-ISOP

--/---/-.77**/-.70**
.87*/.94**
.33*/--

--/---/-.80*
--/---/---/---/--

--/.64*
--/---/-.84*/-.87*/---/--

w-6 FA vs
SBP
Serum Mg
TC
TG
LDL-C
TC/HDL-C

.30*/---/-.55*/---/-.76*/.75**
--/--

--/---/-.71*
--/---/---/---/--

--/---/---/-.76*/-.76*/-.85*/--

Trans FA vs
DBP
Serum Fe

--/--.45*/--

--/---/--

--/.65*
-.84**/--

Dietary cholesterol vs
SBP
.35*/-HGB
--/.49*
Serum Mg
-.39**/-Serum P
--/-PTH
--/.78*
ABTS
--/-.45*

--/---/--.54*/-.61/---/---/--

.42*/.58*
--/.68**
--/---/---/---/--

Vitamin A vs
SBP
Creatinine
Serum Fe

--/---/---/--

--/.58*
--/.66**
.75**/--

--/---/---/--
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Carotene vs
SBP
Creatinine
Serum Fe
Serum P

--/---/---/---/--

--/---/---/---/--

--/.64*
--/.77**
.65*/.96**
--/-.57*

Vitamin C vs
SBP
Serum K
Serum Ca
Kt/V

--/---/-.29*/-na

--/--.60*/---/---/.91**

--/.64*
--/-.40*/-na

Vitamin D vs
Serum K

--/-.44*

--/--

--/-.62*

Vitamin E vs
Serum Fe
Serum Mg
Serum P
PTH

.51*/.85**
--/.44*
--/-.59**/.88**

.69**/.93**
--/---/-.67**/.96**

--/-.43*/-.38*/---/--

Dietary Ca vs
SBP
DBP
Albumin
BUN
Creatinine
Serum Fe
Serum Mg
Serum P
TC
LDL-C
TC/HDL-C
Kt/V

-.40**/-.53**
-.40**/-.53**
--/--.35*/--.58**/-.51*
--/---/-.31*
-.31*/---/--.80*/---/-na

--/---/---/---/---/-.77*
.59*/.86**
--/---/---/---/---/---/.90**

-.45/--.42*/---/-.64*
--/---/---/---/---/--.85*/--.80*/
-.86*/-na

Dietary P vs
Albumin
Serum Fe
Serum P
Renal prof 2

--/---/---/-na

--/-.72*
--/-.56*/-na

--/---/-.56*
--/---/--

Dietary Na vs
SBP
BUN
Creatinine
Serum Na

--/--.37*/--.45**/-.30*/.45*

--/---/---/---/--

.44*/---/---/---/.55*
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Serum Ca
Serum Mg
GFR

--/-.44*
-.46**/-.52*
na

--/---/-na

--/---/---/-.51#

Dietary K vs
Albumin
Serum Mg

--/---/-.45*

--/-.72*
--/-.71*

--/---/--

Dietary Mg vs
Albumin
Serum Fe
PTH

--/---/.56*
--/--

--/-.90**
--/-.65**/--

--/---/---/--

Dietary Fe vs
Serum P

--/--

--/--

--/-.56*

Dietary Se vs
SBP
HGB
Albumin
BUN
Serum Fe
Serum P

.30*/---/---/---/---/.56*
--/--

--/---/---/.87**
-.56*/---/-.67**/--

--/---/.61*
--/---/---/---/--

Antioxidants vs
SBP
Fe
BUN
Creatinine
TBARS
GFR
Kt/V

--/-.51*/.73**
--/---/---/-.37#
na
na

--/-.64*/--.50*/---/---/-na
--/.95**

--/.76**
--/---/---/.61*
-.35#/---/-.52#
na

-.71*/---/-.61*/.73*
-.47#/---/-.68#
--/.87**

--/.75**
--/.59*
--/---/---/-na

Antioxidants+w-3 FA vs
SBP
--/-Hgb
--/-Fe
.48*/.55*
BUN
--/-Creatinine
--/-Kt/V
na

*: p<.05
**: p<.01
#: 0.10>p>0.05
--: not significant
ƒ: renal profile 2, composite score (sum of z scores of BUN and creatinine)
na, not applicable
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Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; Hgb,
hemoglobin; BUN, blood urea nitrogen; Fe, ferritin; Na, sodium; K, potassium; Ca,
calcium; Mg, magnesium; P, phosphorus; PTH, parathyroid hormone; 8-ISOP, 8Isoprostanes; TBARS, Thiobarbituric Acid Reactive Substances; ABTS, 2,2’-Azino-di-[3ethylbenzthiazoline sulphonate]; TC, total cholesterol; HDL-C, high-density lipoprotein
cholesterol, LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; Renal prof 2, z
scores (BUN + creatinine); GFR, glomerular filtration rate; Kt/V = adequacy of dialysis; w3 FA, omega-3 fatty acids
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Table 17: Bone health nutrients based on antioxidants (vitamins A, C, E and
selenium) with or without w-3 Fatty Acids
24-hr recall
Antioxidants

Lowest 1/3

Middle 1/3

Highest 1/3 p

Vitamin D (µg)

4.5±4.2

13.5±11

9.3±6.6

ns

Ca (mg)

437±83a

763±113b

770±112b

=.046

P (mg)

321±73a

672±76b

970±148c

=<.001

K (mg)

646±160a

1195±156b

1717±243b

=.001

Mg (mg)

59±12a

120±17a

214±34b

<.001

Total protein (g)

49±5.4a

63±5.8a

85±7.6b

<.0001

Protein (g/kg)

0.94±0.12a

2.23±0.37b

2.30±0.31b

=.003

Antioxidants
+ w-3 FAs

Lowest 1/3

Middle 1/3

Highest 1/3

Vitamin D (µg)

4.9±4.5

18.7±11.6

2.5±0.8

ns

Ca (mg)

499±92

700±113

764±113

ns

P (mg)

261±56a

818±124b

837±106b

<.0001

K (mg)

520±103a

1381±230b

1588±177b

=.001

Mg (mg)

50±10a

138±21b

198±32b

<.0001

Total protein (g)

47±5.1a

68±7.2b

81±6.6b

=.004

Protein (g/kg)

1.18±0.24

2.05±0.35

2.19±0.31

=0.068

3-day records
Antioxidants

Lowest 1/3

Middle 1/3

Highest 1/3

Vitamin D (µg)

3.8±1.3

9.9±5.8

4.3±1.3

ns

Ca (mg)

493±118

957±164

944±176

=.085

P (mg)

510±95a

680±109ac

1034±167bc =.028
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K (mg)

1095±184

1295±191

1825±346

ns

Mg (mg)

86±20a

123±17a

211±42b

=.017

Total protein (g)

50±7.5

57±6.0

80±12.2

ns

Protein (mg/g)

1.02±0.20

1.94±0.35

2.35±0.53

ns

3-day records
Antioxidants
+ w-3 FAs

Same as above

Abbreviations: Ca, calcium; P, phosphorus; K, Potassium; Mg, magnesium; w-3 FAs,
omega-3 fatty acids; kg, body weight in kilograms, ns, not significant
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Figure 1: Systolic and diastolic blood pressure (mmHg) in four groups of children. Vertical
bars with different letters are significantly different from each other
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure
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Figure 2: Energy and macronutrient intake as percent of recommendation at different
stages of chronic kidney disease. Bars with different superscripts are significantly
different from each other. Dash line represents 100% of recommmendations.
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Figure 3: Intakes of nutrient related to bone health (top) and intakes of nutrient with antioxidant properties (bottom) at different stages of chronic kidney disease based on 3-day
dietary records. Dash line represents 100% of recommendations.
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Figure 4. Pathogenesis of secondary hyperparathyroidism.
http://www0.sun.ac.za/aotc/general/renal/rod.png
Abbreviations: PTH, parathyroid hormone; Ca++, calcium; P, phosphorus
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ABSTRACT
EFFECTS OF DIETARY INTAKE OF ANTIOXIDANTS AND OMEGA-3 FATTY ACIDS
ON FREE RADICAL PRODUCTION IN CHILDREN AT VARIOUS STAGES OF
CHRONIC KIDNEY DISEASE
by
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Degree: Doctor of Philosophy
The purpose of this study was to understand the relationship between dietary
intake of antioxidants and omega-3 fatty acids (w-3 FAs) on free radical injury and free
radical scavenging in children with chronic kidney disease (CKD) so that complications of
kidney failure, especially cardiovascular disease, may be avoided or delayed. Children
with CKD on dialysis and post renal transplantation are at an extremely high risk for
cardiovascular morbidity and mortality. We hypothesized that children with CKD who
have higher dietary intake of antioxidants and w-3 FAs, would have lower free radical
injury, as measured by 8-Isoprostanes (8-ISOP) and Thiobarbituric Acid Reactive
Substances (TBARS) and higher free radical scavenging, as measured by ABTS (2,2’Azino-di-[3-ethylbenzthiazoline sulphonate]) compared to children with CKD with lower
intakes of these nutrients. Pre-dialysis was the baseline comparative group for this study.
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Nutrient intake was assessed by means of a 24-hour diet recall obtained prior to a routine
blood draw and the child or parents/caregivers were asked to complete and return 3-day
dietary records by mail.

Nutrient intakes were analyzed using the software Food

Processor® Nutrition Analysis by EHSA. Forty-seven children with CKD, 3 to 21 years of
age, 72.3% males were enrolled from the Detroit Medical Center (DMC) - Children’s
Hospital of Michigan (CHM) Specialty Center. The results showed that high blood lipid
levels were correlated with oxidative stress biomarkers. Antioxidant intake was not
correlated with oxidative stress, however antioxidant intake with w-3 FAs increased blood
hemoglobin and ferritin levels that may vary with free radical injury and free radical
scavenging biomarkers. High cholesterol intake reduced ABTS levels. Children on
dialysis with higher intake of antioxidants with w-3 FAs had better dialysis outcome (Kt/V)
and control of SBP. High triglyceride levels were shown to impair renal function and may
affect bone health. Clinical implications include counseling by a renal dietitian about foods
high in antioxidants, w-3 FAs, and calcium to lower blood pressure, improve blood lipid
levels and renal function, and indirectly reduce oxidative stress.
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